Cloning and Characterization of SAS1738, a Hypothetical Exported Protein from Community-Associated Strain of Staphylococcus Aureus by Vijaya Kumar, Deepak Kumar
CLONING AND CHARACTERIZATION OF SAS1738, A HYPOTHETICAL 
EXPORTED PROTEIN FROM COMMUNITY-ASSOCIATED STRAIN OF 
STAPHYLOCOCCUS AUREUS 
_____________________ 
A dissertation 
Presented to 
The College of Graduate and Professional Studies 
Department of Biology 
Indiana State University 
Terre Haute, Indiana 
______________________ 
In Partial Fulfillment 
Of the Requirements for the Degree 
Doctor of Philosophy 
_______________________ 
By 
Deepak Kumar Vijaya Kumar 
August 2010 
 Deepak Kumar Vijaya Kumar 2010 
 
Keywords: SAS1738, CA-MRSA, C. elegans, MSSA476, Bacteriocins 
 
 
ii 
 
 
 
COMMITTEE MEMBERS 
Committee Chair: H. Kathleen Dannelly, PhD 
 Associate Professor, Biology: Microbiology 
 Indiana State University 
Committee Member: Swapan K. Ghosh, PhD 
 Professor, Biology: Immunology 
 Indiana State University 
Committee Member: James P. Hughes, PhD 
 Professor, Biology:  Molecular/Cellular Endocrinology 
 Indiana State University 
Committee Member: Gary W. Stuart, PhD 
 Professor, Biology: Molecular and Developmental Genetics 
 Indiana State University 
Committee Member: Margaret M. Moga, PhD 
 Associate Professor, Anatomy and Cell Biology 
 Indiana University School of Medicine 
 
  
iii 
 
 
 
ABSTRACT 
Methicillin resistant Staphylococcus aureus (MRSA) is a group of S. aureus strains that 
has acquired resistance to a class of beta lactam antibiotics and is the major cause of hospital 
associated infections. Their discovery goes back to 1960 when the first cases were identified. 
Recently community associated MRSA infections have emerged and are caused by strains that 
are independent of those from the hospital environment, related only because they carry some of 
the same antibiotic resistance genes. Community associated infections (CA) are more severe, 
producing pus filled lesions that are painful and capable of invasion of deep tissues. Virulence 
factors comprised of exported proteins are associated with the invasiveness of CA strains. Most 
of these proteins are hypothetical in nature with unknown function.  
The aim of this study is to identify and characterize potential virulence factor proteins 
that may be involved in the infection pathway of CA-MRSA. This study focuses on a unique 
gene that encodes an exported protein, SAS1738, found on the chromosome of the CA strain 
MSSA476.  The protein SAS1738 was chosen because it is unique to CA strains and has 
homology to some proteins identified in other S. aureus strains known for their virulence and 
host immune evasion. The goal of this work is to characterize SAS1738 and to determine its role 
in the infection pathway of the organism. The gene of interest has been successfully cloned, 
expressed, and tested for toxicity in Caenorhabditis elegans, a nematode. The toxicity tests 
showed that SAS1738 is inhibitory to the growth and development of C. elegans. The actual 
mode of action of this protein in C. elegans is yet to be established. However, location of 
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SAS1738 using a GFP fusion showed that the highest concentration of the fusion protein was in 
the gut of the worms. The purified protein when tested in a killing assay against C. elegans, 
resulted in the death of the worms at an average time point of 8 min after treatment. 
 Microbiological assay results showed that the purified SAS1738 possessed antibacterial 
activity towards Micrococcus luteus and Proteus vulgaris. This suggests that SAS1738 may play 
a dual role of antagonizing the commensal flora of the human skin such as Micrococcus luteus 
and also induce a toxic effect on the human cells as suggested by its toxic effect on C. elegans.  
Determination of the role of this protein in the infection cycle of CA-MRSA will lead to a better 
understanding of the pathogenicity of the organism and possible development of new treatment 
strategies. 
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PREFACE 
The aim of this dissertation is to highlight the importance of studying the as yet 
uncharacterized hypothetical proteins in community associated (CA) Staphylococcus aureus. 
This work particularly focuses on SAS1738, one of the many as yet uncharacterized proteins 
produced and secreted by this group of bacteria. Based on the assays performed using both 
prokaryotic and eukaryotic systems SAS1738 is suggested to possess a dual function of 
inhibiting other normal flora of the skin and also play a role during the infection with a CA strain 
of Staphylococcus aureus. 
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CHAPTER 1 
 
INTRODUCTION 
Part I 
 
Staphylococcus aureus is a Gram positive bacterium that is often implicated in bacterial 
infections. It is an opportunistic pathogen that permanently colonizes about 20% and transiently 
colonizes about 60% of the population. The infections caused by these pathogens, after they 
manage to cross the barrier created by the epidermal or the mucosal layer by means of virulence 
factors, are wide-ranging. Diseases caused by S. aureus may involve skin, soft tissues, bone 
(osteomyelitis and septic arthritis), heart (endocarditis) and lungs (pneumonia). Numerous 
extracellular proteins produced by different strains make it difficult to evaluate the pathogenic 
mechanism of this bacterium because not all of these proteins are known or characterized. 
Though most of these proteins do not appear to be toxins, studies have shown that some of them 
enhance virulence (Abramson 1973) and thus contribute to the increased invasiveness of S. 
aureus by evading the host immune system. Some of the known toxins of S. aureus are 
enterotoxins, exfoliative toxins, toxic shock syndrome toxin, and other exotoxins. Food 
poisoning, toxic shock syndrome and scalded skin syndrome are some of the most common 
infections caused by secreted toxins.   In addition, these bacteria also secrete proteases, lipases, 
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nucleases, phosphatases, phospholipases, coagulase and staphylokinase all of which play roles 
during a Staphylococcal infection.  
Methicillin resistant Staphylococcus aureus (MRSA) is a group of S. aureus strains that 
has acquired resistance to a class of beta lactam antibiotics and is the major cause of many 
hospital associated (HA) infections. Their discovery goes back to 1960 when the first cases of 
methicillin resistant strains were identified after the introduction of methicillin. Since 1960, 
MRSA in hospitals has increased at a rapid rate. Clonal expansion and gene transfer within the 
already existing lineages have been implicated as the causes for the rapid increase in MRSA 
disease rates.  
Recently, community associated (CA) MRSA infections have emerged and are caused by 
strains that are independent of those strains common in the hospital environment. CA and HA 
MRSA are related only because they carry many of the same antibiotic resistance genes. While 
the HA strains are resistant to a broad range of antibiotics, such as erythromycin, tetracycline and 
clindamycin, the CA strains are resistant only to erythromycin and the β-lactam group of 
antibiotics (CDC). Nonetheless, community associated (CA) infections are more severe, 
producing pus-filled lesions that are painful and capable of invasion of deep tissue. Virulence 
factors associated with CA strains mostly comprise exported proteins. Most of these proteins are 
hypothetical in nature with unknown functions. In addition to carrying a smaller number of 
antibiotic resistance genes compared to the HA strains, the CA strains harbor the staphylococcal 
chromosome mec type IV cassette (SCCmec). The type IV cassette is less complex than types I, 
II or III found in the HA strains and hence may contribute to the increased flexibility of the CA 
strains.  
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Genome organization in S. aureus 
The S. aureus genome is broadly divided into core (78%) and accessory (22%) domains. 
The core segment carries genes that are acquired through vertical transfer while the accessory 
segment has horizontally transferred genes. The core domain comprises genes that are mostly 
conserved among different strains of S. aureus, and play essential roles in metabolic and 
housekeeping activities. Variations in genes such that more than ten protein coding sequences are 
affected are usually a result of horizontal gene transfer. The genes that make up this variation 
comprise the accessory genome and encode proteins with virulence and antibiotic resistance 
properties. Pathogenicity and genomic islands, transposons and bacteriophages, and SCC 
elements are all part of this accessory segment. The variation in accessory genomes causes size 
difference among different S .aureus genomes that range from 2,799,802 to 2,902, 619 bp (Chan, 
Sherman et al. 2006). Species specific genes that differentiate S. aureus from other species of 
Staphylococcus (Lindsay and Holden 2004) are found in the core genome. This includes 
coagulase, Protein A (Spa), alpha and gamma hemolysins (hla and hlg), capsular polysaccharide 
biosynthesis (cap), etc. Common infections caused by S. aureus rely on the species specific 
genes, whereas the genes that comprise the accessory genome are scattered throughout the core 
genome, are involved in toxin-mediated infections, and are not common to all S. aureus 
infections. While the stable core domain is maintained and conserved through vertical species-
specific gene transfer, the accessory domain, transferred by horizontal gene transfer, is highly 
variable. The ability to easily acquire or lose new genes makes it a primary force behind the 
evolution of novel strains, with additional virulence and antibiotic resistance traits.  
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Elements of the core genome 
Genomic islands 
Genomic islands of the core genome are regions that, unlike the accessory genome, 
display minor variations in their genes. These variations in the gene sequences are not in 
association with point mutation or insertional elements (Hiramatsu, Watanabe et al. 2004; 
Holden, Feil et al. 2004), and their protein products are usually involved in the metabolic 
pathways of the organism, with an exception of SAR0285-SAR0291 islet of MRSA252. The 
genomic island of HA-MRSA strain MRSA252 is well studied and has 41 unique genes whose 
sequences have been deduced. One of the islets that spans genes SAR0285-SAR0291 lies next to 
a genetic locus that resembles a conserved region in Mycobacterium tuberculosis (Pallen 2002) 
and is involved in producing a 6 kDa early secreted antigen target (ESAT-6) and a 10 kDa 
culture filtrate antigen (CFP-10), encoded by esxA and esxB (Stanley, Raghavan et al. 2003). 
This ESAT-like locus in MRSA252 is unique in that the esxB and esaC genes are absent in this 
strain but present in all the other sequenced S. aureus strains. Sequence comparison of genes 
from the two HA strains MRSA252 and Mu50 show similarity between many of its genes 
flanking the ESAT-6-like locus. The CA strains, MSSA476 and its close relative MW2, possess 
nine orthologs of SAV0294, a gene flanking the downstream terminal of the ESAT-6-like cluster 
in Mu50. SAV0294 protein also has significant homology to proteins encoded by 11 genes from 
another HA strain, COL.    
Coagulase is an enzyme that is produced only by S. aureus and is used in differentiating 
it from other non-pathogenic strains. The gene encoding coagulase, coa, displays a wide 
variation among strains, and their allotypes share only about 65% to 88% amino acids. But 
presence of two distinct coa alleles only in closely related strains indicates a lateral gene transfer. 
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Another genomic islet gene is the collagen adhesion (cna) gene because it is devoid of any 
connection with mobile genetic elements (Gillaspy, Patti et al. 1997) and also is found in fewer 
strains. 
Adhesion islands 
Adhesion islands are genomic islands whose genes encode proteins that function in 
adhesion activities. The Cna protein belongs to the MSCRAMM protein family, whose main 
function is to adhere to the extracellular matrix of tissues. Because of its insertion between genes 
of the core genome the cna gene is part of a genomic island. The cna gene is believed to enhance 
virulence because it is associated with strains that cause severe necrotizing pneumonia and 
cartilage infections (Bentzmann, Tristan et al. 2004). Other important genomic islet genes are 
fnbA and fnbB that encode the fibronectin-binding proteins FnBPA and FnBPB. These belong to 
the MSCRAMM family as well and their genes found in most sequenced S. aureus genomes 
except the HA strain MRSA252 which has only fnbA (SAR2580). In MSSA476,  fnbA 
(SAS2388) and fnbB (SAS2387) are flanked by a nucleotidyl transferase gene, SAS2386 and a 
gluconate permease gene, SAS2390. The same corresponding genes, SAR2579 and SAR2582, 
flank fnbA in MRSA252 (Chan, Sherman et al. 2006). Two gene products, sarT (SAS2385) and 
sarU (SAS2384), located in the same islet in MSSA476, belong to the Sar protein family 
involved in virulence (Cheung and Zhang 2002). The accessory gene regulator (agr) is an 
important complex in the expression of virulence proteins during S. aureus infection and is 
regulated by the combined activity of sarT and sarU along with sarA (Peng, Novick et al. 1988). 
The lack of this islet in MRSA252 suggests a different mode of virulence protein expression. 
 In MSSA476, a cell wall bound surface protein SasG (SAS2383) shows significant 
homology to a protein from S. epidermidis involved in biofilm formation (Hussain, Herrmann et 
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al. 1997) and also to a MRSA-specific plasmin-sensitive (PI) protein. All three of these are 
associated with adhesion to the nasal epithelial cells, an important stage prior to the colonization 
and infection of S. aureus. 
Pseudogenes 
Another core genome segment, the pseudogenes, consists of altered alleles that result 
from nonsense or frameshift mutations instead of genetic recombination. Among the HA-MRSA 
the evolution of vancomycin resistant strains has been observed and is associated with the 
pseudogenes. The HA strain Mu50 is a vancomycin-intermediate S. aureus (VISA) and is often 
compared to another closely related vancomycin-sensitive HA strain N315 to determine the 
significance of pseudogenes. Comparative studies involving these two strains have shown 
disruption of four genes through point mutations in Mu50, but not in N315. The four disrupted 
genes were unique to the VISA strain Mu50 (Wootton, Avison et al. 2004). Pseudogenes are thus 
considered an important area for study to better understand the origin of novel phenotypic traits 
through genotypic point mutations that can eventually alter an organism’s overall pathogenicity.  
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Elements of the accessory genome 
Bacteriophage and the Panton-Valentin Leukocidin (PVL) toxin 
Three types of S. aureus prophages are encountered in the sequenced genomes and are 
designated ΦSa 1, ΦSa 2, and ΦSa 3 families. ΦSa 1 encodes the exfoliative toxin A (ETA) 
involved in scalded skin syndrome of S. aureus (Yamaguchi, Hayashi et al. 2000).  None of the 
sequenced MRSAs carry this prophage in its active ETA producing form. The ΦSa 3 family of 
prophage carries a sak gene that encodes a plasminogen activator called staphylokinase and is 
found in strains MW2, MSSA476, MRSA252, N315, and Mu5O. The presence of this prophage 
in the genomes disrupts a β-toxin (hlb) encoding gene which is intact in most animal isolates. 
ΦSa 3 also carries several enterotoxin genes, the products of which cause food poisoning such as 
enterotoxin A, and also a few others like the sep, seg2 and sek2 (Holden, Feil et al. 2004; 
Lindsay and Holden 2004). However, one of the most potent toxins to have emerged in CA-
MRSA strains is the PVL toxin. PVL has been implicated in a wide range of cases from life-
threatening necrotizing pneumonia in children to skin and tissue infections among individuals 
from varying sectors of the community. MW2 and Newman are the two most invasive CA-
MRSA strains that carry PVL. They are widespread in multiple sectors like gymnasiums, 
schools, and daycares and have led to increased mortality rates. While HA-MRSA strain, 
MRSA252, possesses a variant form of the ΦSa 2 prophage and does not make PVL toxin, the 
CA strain MSSA476 completely lacks ΦSa 2 and hence lacks PVL toxin. However, CA-MRSA 
MW2, which is suggested to have evolved from MSSA476, has the ΦSa 2 in a region that is 
occupied by SAS1429 in MSSA476. The attachment sites attL and attR required for prophage 
integration are found at the C-terminal end of SAS1429, a 750 amino acid hypothetical protein. 
The ortholog of SAS1429 in MW2 strain is split by the integration of ΦSa 2 in the middle of the 
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gene thus dividing the SAS1429 ortholog in MW2 into two separate coding sequences, MW1377 
and MW1433. SAS1429 is flanked by SAS1426-28 on one side and SAS1430 on the other, and 
is also preceded by srrAB operon (SAS1432 and SAS1431) involved in oxygen dependent gene 
expression of a variety of virulence factors like toxic shock syndrome toxin (Yarwood, 
McCormick et al. 2001; Pragman, Yarwood et al. 2004). It is interesting to note that the 
integration of ΦSa 2 prophage, which harbors the PVL toxin gene, should take place right next 
the srrAB operon that modulates and controls the toxin expression. Though SAS1429 lacks a 
signal peptide its flanking genes SAS1426-28 and SAS1430 possess signal peptides in their 
protein sequences.  
SCCelements 
SCCmec is a genetic cassette that is categorized into six types designated SCCmec type I 
through VI. Within each type there are genetic variations that have been observed (Katayama, Ito 
et al. 2000; Ito, Katayama et al. 2001; Ma, Ito et al. 2002; Okuma, Iwakawa et al. 2002; Ito, Ma 
et al. 2004; Oliveira, Milheirico et al. 2006). SCCmec carries the methicillin resistance gene 
mecA encoding a penicillin binding protein PBP2a with reduced binding affinity for penicillin 
and other β-lactam antibiotics (Lim and Strynadka 2002; Chambers 2003). All types of SCC 
elements are found in the same location adjacent to the origin of replication oriC on the 
chromosome of S. aureus (Hiramatsu, Watanabe et al. 2004). Type I SCC element is the 
suggested to be the first to have arisen after introduction of methicillin in1959, followed by other 
types with additional genes conferring resistance to multiple antibiotics. Type I SCC element has 
only the mecA gene and is found in the hospital strain S. aureus COL. Types II and III SCC 
elements possess, in addition to mecA, other non-β-lactam resistance genes encoding resistance 
to macrolides, aminoglycosides, tetracycline, and heavy metals. While Types I, II and III are 
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found only in HA strains; types IV and V are usually encountered in CA strains, and easily 
undergo horizontal transfer by phage due to their relatively small size. The closely related CA 
strains, MW2 and MSSA476, both possess a type IV SCC element. However, the difference is 
that while MW2 has a mecA gene in its type IV SCC, MSSA476 has a fusidic acid resistance 
gene (SAS0043) (Holden, Feil et al. 2004; Lindsay and Holden 2004) in its Type IV SCC mec-
like element, designated as SCC476. Fusidic acid resistance is suggested to have developed as a 
result of frequent use of fusidic acid in the topical treatment of skin infections caused by S. 
aureus (Osterlund, Eden et al. 2002; Tveten, Jenkins et al. 2002; O'Neill, Larsen et al. 2004). 
Presence of protein domains within this SCC element have homology to domains found in 
another fibronectin-binding protein from Listeria (Gilot, Jossin et al. 2000; Gilot and Content 
2002) . This evidence suggests a possibility that SCC476  may play a dual role of conferring 
fusidic acid resistance and also promoting bacterial adherence to the host fibronectin during 
infection. In addition, it also harbors the recombinase gene ccrAB or ccrC, the presence of which 
facilitates the excision and integration of SCCmec from one region to another on the 
chromosome (Katayama, Ito et al. 2000; Ito, Katayama et al. 2001; Ito, Ma et al. 2004). 
However, all types of SCCmec elements have been found to be integrated at a specific site of 
attachment, attB, present at the end of orfX, a hypothetical reading frame of unknown origin and 
function. The 15 bp nucleotide sequences that encode the five amino acids at the C-terminal end 
of orfX are the core of the attB site of the SCCmecA element. The presence of both the orfX and 
one of the recombinase genes, ccrAB or ccrC, is essential for a strain to become transformed into 
MRSA. When a SCCmec element is inserted, the 15 bp sequence comprising the core attB 
sequence repeats itself after the 15 bp sequence of the orfX and the new SCCmec insert is 
flanked by it on either side (Luong, Ouyang et al. 2002; Katayama, Takeuchi et al. 2003; Holden, 
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Feil et al. 2004; Mongkolrattanothai, Boyle et al. 2004). There are about 162 genetic 
backgrounds that comprise all S. aureus but MRSA is found in only 38 of these (Enright, 
Robinson et al. 2002).  
 The presence of a non mecA SCC element has been observed in Staphylococcus aureus 
MSSA476 which also harbors the recombinase gene ccrAB required for integration/excision 
activity. MSSA476 is unique and a rare exception because it is the only methicillin sensitive 
Staphylococcus aureus (MSSA) tested so far that has ccrAB, a feature characteristic of MRSA. 
Though some MSSA strains carry orfX gene with the 15 bp core attB sequence required for 
SCCmec insertion, the lack of a recombinase gene weakens their potential to acquire SCCmec 
element. Therefore MSSA476 marks a critical point in the evolution of novel strains possessing a 
recombinase and an orfX gene and serving as a source for other more invasive CA-MRSA strains 
such as MW2 and Newman. This idea is further strengthened by the fact that the two genes 
SAS0051-SAS0052 from MSSA476 and their orthologs MW0051-MW0052 from strain MW2  
(Baba, Takeuchi et al. 2002; Holden, Feil et al. 2004), resemble by their homology enterotoxins 
and exotoxins from Staphylococcus and Streptococcus and are found flanking the right boundary 
of the SCC476 and the SCCmec elements of the two CA strains. The absence of these genes in 
HA strains, N315 and Mu50, indicate these are unique to the CA strains and show that 
MSSA476 could be the potential precursor CA strain that led to the emergence of CA strains like 
MW2, with additional characteristics acquired through shuffling of genes in the SCC element 
(Mongkolrattanothai, Boyle et al. 2004).  
S. aureus pathogenicity islands (SaPI) 
There are four types of SaPIs designated as SaPI(1-4) based on their insertion sites and 
the integrase homologies. The well-characterized SaPI2 is found in the two HA strains, Mu50 
11 
and N315, close to a ΦSa3 prophage. The phage related activities can cause excision and phage-
packaging of SaPi2 (Ruzin, Lindsay et al. 2001). This promotes the dissemination of the SaPI2 
family that carries genes encoding toxic shock syndrome toxin (tst) and enterotoxins. Another 
HA strain, S. aureus COL, carries SaPI1 which is found in the vicinity of sufB gene 
(SACOL0918) in close association with the ΦSa1 attachment sites. SaPI carries SACOL0908 
encoding a putative β-lactamase (ear) protein. The COL strain carries only the ΦSa1 attachment 
sites but is not lysogenised. However, Mu50 carries the ΦSa1 prophage, as well as, a SaPI3 
family protein but not SaPI1. The presence of a phage and SaPI3 and the potential to acquire the 
SaPI1 family near a coa allele makes this particular region a vulnerable zone for horizontal gene 
transfer in Mu50. This also explains why closely related strains possess distinct coa alleles while 
the distant strains share the same alleles (Hiramatsu, Watanabe et al. 2004). 
 In the CA strain MW2, a SaPI3 family is present in the same location of the genome as 
that of another SaPI3 family member in the HA strain Mu50. However, in MW2 the SaPI3 
family has genes that encode a putative β-lactamase and two enterotoxins (Baba, Takeuchi et al. 
2002) similar to that of the SaPI1 of the COL strain. The HA strain MRSA252 carries only a 
single SAPI4 family of pathogenicity islands, while MSSA476 completely lacks these 
pathogenicity islands, proving the high variability in these regions. The toxic shock syndrome 
(tst) toxin is the only clinically significant toxin associated with specific disease characteristics 
during infections. But due to its low incidence rate, tst alone cannot be used to evaluate the 
virulence enhancing role of pathogenicity islands. Hence in the virulence mechanisms of S. 
aureus the significance of pathogenicity islands is unclear and an area that deserves more study. 
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Genetic elements and islands (GEIs) 
GEIs are of two types, vSaα and vSaβ positioned at 2 and 8 o'clock, respectively, on the 
chromosome map. They differ from the pathogenicity island SaPI2 by carrying a truncated 
transposase and unlike SAPI2 they lack any prophage association. Both vSaα and vSaβ harbor 
the DNA methylase gene, hsdM, and another gene hsdS that flanks hsdM and functions in the 
specificity of the methylase activity. Because of the presence of these methylation associated 
genes in the GEIs, vSaα and vSaβ are constantly transferred to a new genome without being 
excised. If excluded from the genome, the lack of methylation can allow restriction 
endonucleases to digest the genomic DNA (Kuroda, Ohta et al. 2001).  These two elements also 
harbor a sequence of duplicated virulence genes that are putative in nature.  
 In vSaα, on the 5’ end of the centrally located hsdM/hsdS, set genes are found in 9-11 
tandem repeats and bear homology to exotoxin superantigens from other S. aureus. The 3’ end is  
flanked by 3-9 tandem repeats of putative lipoprotein encoding genes, lpl. These exotoxins are 
suggested to play essential roles in destroying the host leukocytes (Kuroda, Ohta et al. 2001) 
contained within an abscess formed due to the regional inflammatory response induced by S. 
aureus infection. 
 In vSaβ, the hsdM/hsdS is located on the 3’-side next to the hypothetical transposase, and 
is flanked by the spl genes that are found in about five tandem repeats. The putative serine 
proteases (SplA-SplF) encoded by these genes carry a histidine active site signature sequence 
that is characteristic of the V8 family of serine proteases. The SplA-SplF proteins are 
significantly homologous to exfoliative toxins A and B (EtA and EtB), that are also glutamyl 
endopeptidases, and also to SspA, another glutamyl endopeptidase V8 serine protease protein 
encoded by the core genome. However, despite the absence of the spl genes by deletion in S. 
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aureus strain RN6390, experiments have shown that there has not been any reduction in the 
virulence of S. aureus (Reed, Wesson et al. 2001).  
The vSaβ is further divided into types I and II (Baba, Takeuchi et al. 2002). The HA 
strains MRSA252, N315 and Mu50 carry type I with the exception of the COL strain which 
carries type II. The CA strains that have been sequenced carry type I. In type I vSaβ, the spl 
genes are in close proximity to the leukotoxin encoding genes lukD and lukE, and also to some 
putative enterotoxin genes. Interestingly, in the CA strains MSSA476 and MW2, the spl genes 
are separated from the lukD and lukE by an intervening sequence that harbors genes homologous 
to the lantibiotic synthesis genes involved in the synthesis of a peptide lantibiotic, epidermin, in 
S. epidermidis. This suggests that the CA strains MSSA476 and MW2 may have acquired this 
cluster of genes to fight off the competition posed by other normal flora of the skin by making 
the bacteriocin (Baba, Takeuchi et al. 2002). Also the presence of type I vSAβ in the first HA 
strains that evolved further strengthens this hypothesis because as more multiple drug resistant 
HA strains emerged, the need for this bacteriocin gene cluster  became obsolete and the newer 
strains replaced it with leukotoxin and exotoxin encoding genes. 
Bacteriocins and lantibiotics 
Bacteriocins are peptides synthesized by some bacteria that have antibacterial or 
inhibitory effect against a narrow range of other bacteria. They are highly diverse in size, target, 
mechanism of action, and mode of immunity. Both gram positive and the gram negative bacteria 
produce these molecules. One widely studied bacteriocin is the colicin of E. coli. Colicin gene 
clusters are usually found on plasmids and they harbor separate genes encoding the colicin toxin, 
an immunity protein and a lysis protein that facilitates the extrusion of the synthesized colicin 
from the cell. Colicin synthesis and secretion are under the control of a SOS regulon which is 
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induced under stress (Braun, Pilsl et al. 1994; Cramer, Heymann et al. 1995; James, Kleanthous 
et al. 1996).   
Gram positive bacteriocins are more diverse than those produced by the gram negative 
bacteria (Tagg, Dajani et al. 1976; Jack, Tagg et al. 1995). Their synthesis is not necessarily an 
activity that results due to stress. A specific protein transport mechanism, sometimes involving a 
sec-dependent pathway, exports the bacteriocins from the cell resulting in a less lethal event than 
in the gram negative bacteria. Their production is under the regulation of a bacteriocin-associated 
operon. 
Classes of bacteriocins 
Three classes based on the diverse production of bacteriocins by the lactic acid bacteria 
have been identified (Klaenhammer 1988). Class I are the lantibiotics named for their post-
translational modification that that results in the addition of amino acids like lanthionine and β-
methyllanthinone . There are two types of lantibiotics based on their mode of killing the target 
cell and unique structural characteristics (Jung 1991). Type A lantibiotics such as nisin are in the 
size range of 21-38 amino acids and kill the target cell by depolarization of the cell membrane 
causing pores and eventual lysis of the cell (Schuller, Benz et al. 1989; van Belkum, Hayema et 
al. 1989). Type B globular lantibiotics are in the size range of about 19 amino acids and kill the 
target by interfering with enzymatic activity involved in cell wall synthesis (Brotz, Bierbaum et 
al. 1995). An example of a type B lantibiotic is mersacidin. 
 Class II bacteriocins of the well studied lactic acid bacteria are heat-stable and comprise 
30-60 amino acids (Jung 1991). They are further classified into class IIa and class IIb. Class IIa 
bacteriocins are similar in their mode of action to type A lantibiotics and kill the target by pore 
formation. All the class IIa bacteriocins identified thus far, pediocin AcH (Bhunia, Johnson et al. 
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1987), sakacin A (Schillinger and Lucke 1989), and leucocin A (Hastings, Sailer et al. 1991), 
harbor a conserved sequence of amino acids (YGNGVXaaC) and show inhibitory effect towards 
Listeria. Class IIb bacteriocins are a smaller group as compared to class IIa and include lacticin F 
(Muriana and Klaenhammer 1991) and lactococcin G (Nissen-Meyer, Holo et al. 1992) . Their 
mode of action is to form pores made of two different proteins in the target cell membrane.   
 Class III bacteriocins such as helveticins J and V  (Joerger and Klaenhammer 1986; 
Vaughan, Daly et al. 1992) and lactacin B (Barefoot and Klaenhammer 1984) are generally 
larger than the other classes and heat-sensitive.  
 The Gram positive bacteriocins are more complex in their synthesis and involve a myriad 
of genes found in a cluster. A well characterized example is the nisin-producing genetic 
machinery comprised of nisA, encoding a prepeptide; nisB and nisC, encoding amino acid 
modifying proteins; nisP, encoding a leader-peptide cleaving enzyme; nisT, encoding a 
secretion-associated product; nisI and nisFEG, encoding immunity proteins; and nisR and nisK, 
encoding regulatory proteins (Buchman, Banerjee et al. 1988; Kaletta and Entian 1989; Engelke, 
Gutowski-Eckel et al. 1992; Kuipers, Beerthuyzen et al. 1993; Engelke, Gutowski-Eckel et al. 
1994; Ra, Beerthuyzen et al. 1999). Most of these genes are clustered on transposons (Dodd, 
Horn et al. 1990) in plasmids but sometimes they are also found on the chromosome.  
 It is a general opinion that bacteriocins kill other closely related bacteria. However, type 
A bacterocins, nisin A and mutacin B-Ny266, kill a broad range of bacteria that includes 
Streptococcus, Staphylococcus, Clostridium, Micrococcus, Listeria, Mycobacterium, 
Propionibaacterium, Corynebacterium, and Bacillus (Mota-Meira, LaPointe et al. 2000). 
Clinically significant gram negative bacteria like Neisseria, Campylobacter, Haemophilus, and 
Helicobacter have also been shown to be killed by bacteriocins (Mota-Meira, LaPointe et al. 
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2000). Bacteriocin production starts during mid-log phase and peaks in the stationary phase 
(Buchman, Banerjee et al. 1988). The culture concentration and not the cell cycle is said to 
influence the expression of bacteriocins. As seen in the quorum sensing machinery, the 
bacteriocin production is dependent upon a two component regulatory system involving a 
response regulator and a sensor kinase (De Ruyter, Kuipers et al. 1996) . The nisR gene encodes 
the response regulator protein and nisK gene encodes the sensor kinase during the production of 
nisin. 
Due to the antibacterial properties they possess, ribosomally synthesized bacteriocins are 
said to be secreted in order to antagonize the other bacterial flora that may occupy the same 
niche of the host. This potential to kill other bacteria has been tapped and some bacteriocins such 
as nisin and pediocin PA1/AcH are used in food preservation. 
Staphylococcal bacteriocins 
Bacteriocins produced by the Staphylococcus group of bacteria are called staphylococcins 
the best characterized being epidermin synthesized by S. epidermidis. Other staphylococcins 
include Pep 5, epilanciin K7, and epicidin 280. 
 The genes involved in the synthesis and production of lantibiotics in Staphylococcus 
aureus in general, and CA-MRSA in particular, is collectively called bacteriocins of 
Staphylococcus aureus (Bsa). Staphylococcin C55 is the only compound that has so far been 
proven to be a lantibiotic. But staphylococcin Au-26 produced by a vaginal isolate of S. aureus 
kills a broad range of targets like Streptococcus pyogenes, Streptococcus salivarius, Streptocccus 
mutans, Staphylococcus hominis, Staphylococcus warneri, Lactococcus, and Neisseria sp. 
Staphylococcin Au-26 and the Bsa genetic loci have been shown to be identical using mass 
spectrometry and mutagenesis (Daly, Upton et al. 2010).   
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 Among other bacteriocins of S. aureus, aureocins A70 and A53, designated as class II 
bacteriocins, are the best characterized. While aureocin A70 is a bacteriocin, encoded on the 
plasmid pRJ6 and comprised of four related peptides, aureocin A53 is composed of 51 amino 
acids and is encoded on plasmid pRJ9. Since isoleucine is the first amino acid of both 
staphylococcin AU-26 and epidermin, made by S. epidermidis, it has been suggested that the two 
may be identical in their antibacterial activity. Sequencing results of the genes encoding these 
two lantibiotics indicated that they are highly homologous to corresponding regions of the type II 
vSaβ islands of many other sequenced strains of S. aureus linked to putative Bsa lantibiotics 
suggesting that the Bsa genes in the corresponding loci may be closely related to the well 
characterized epidermin and gallidermin produced by S. gallinarum . However, lack of 
homologues to BsaH or BsaT involved in the export of epidermin and galidermin suggests a 
different mode of export for lantibiotics encoded by bsa genes. The CA strains MW2, FPR3757, 
USA300, Newman, and MSSA476 harbor the bsa genes on their type II vSaβ genomic islands. 
The bovine mastitis associated strain, RF122, carries corresponding bsa genes that are related but 
not identical to those found in CA strains. But the HA-MRSA strains, MRSA252, N315, Mu50, 
and JH1, lack these genes in their types I or III islands. 
 Bacteriocins in general can be considered cytolytic virulence proteins because they 
provide the producer an ecological advantage in colonizing the host. Mutacins of Streptococcus 
mutans, streptococcins of Streptococcus pyogenes and staphylococcin C55 produced by S. 
aureus possess a cytolytic function that is no different from the actual cytolysin produced by the 
enterococci. The immunity proteins that each of these strains produce are specific and do not 
confer immunity to strains that make similar bacteriocins, hence production of these 
antibacterials constitutes a major factor in the pathogenesis of a single strain. 
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 This study focuses on a unique gene that encodes a hypothetical exported protein 
SAS1738 found on the chromosome of a methicillin sensitive CA strain MSSA476.  The protein 
SAS1738 was chosen because it is part of the accessory genome of MSSA476 and has relevant 
homologies to proteins from two other CA strains, MW2 and Newman, which makes it unique to 
the CA-MRSAs. MSSA476 is one of the first Staphylococcus aureus strains to be characterized a 
CA strain and is believed to be the first of its kind. Other CA strains like MW2 and Newman 
evolved later, acquiring additional genes encoding Panton Valentine Leukocidin (PVL) factors, 
and proteins that confer methicillin resistance. However, the continuous presence of the 
SAS1738 coding gene in all the recently emerged CAs seem to suggest that this protein plays an 
essential, significant role in the invasiveness of the CA strains.  
 We cloned and expressed the gene encoding SAS1738 in E. coli BL21 A1shot cells 
(Invitrogen). The protein was purified and tested by microbiological assay. Strong zones of lysis 
were observed against Micrococcus luteus, Proteus vulgaris, and Pseudomonas aeruginosa. No 
lysis was observed with the control samples. Based on the antibacterial properties displayed by 
SAS1738, we suggest that SAS1738 has a greater role in the infection pathway of the CA strains 
to aid in competition and antagonism of commensal microflora to occupy a certain niche and 
colonize the human skin and mucosa. While much work is yet to be done to understand the role 
of SAS1738 in the invasiveness of CA strains, it is clear that the effect of SAS1738 on other 
pathogens, especially Pseudomonas aeruginosa and Proteus vulgaris, well known for natural 
resistance to antibiotics commonly used in the clinical setting, make it a potential candidate for 
development as a treatment of certain bacterial infections in topical applications and possibly as 
a food preservative. 
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Part II 
Caenorhabditis elegans 
Caenorhabditis elegans is a nematode which serves as an efficient eukaryotic model for a 
wide range of studies. C. elegans metabolic pathways are conserved among the vertebrate 
eukaryotes making it a powerful system to determine the effects of toxins and other chemicals 
with respect to human biology. The presence of immune and nervous system and many common 
features that represent the cellular signaling pathways in humans and their sensitivities to heavy 
metals and human neuroactive drugs further justifies their widespread use in research (Nguyen, 
Alfonso et al. 1995). C. elegans is easy to grow; each adult worm is able to lay 300-1000 eggs 
every 3 to 5 days. Most worms are hermaphrodites, and thus do not require separate mating 
sessions in the laboratory, allowing for rapid experimental observations. The small size, 
approximately 1 mm in length, and transparent nature of the nematode are added advantages. 
Fusion proteins can be easily traced and protein expression can easily be visualized 
microscopically inside the worms. Another important area of research currently being explored 
with C. elegans is RNA interference studies.  
Unusual movements of worms seen under the dissection microscope have been correlated 
with toxicity and this is one of the most important uses of these worms in research. Death due to 
toxic effects of the compound being studied can be determined by gently touching the worm with 
an eyebrow hair or a thin metal wire; lack of movement indicates death. Fluorescent dyes that 
can detect dead worms are sometime used to perform the above assay under a fluorescence 
microscope or using a fluorescent plate reader. C. elegans feeds on E. coli and the strain of E. 
coli that is commonly used in the laboratories for cultivation is the OP50 strain which is a uracil 
auxotroph. Both liquid and solid media can be used for growth.  
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Anatomy of C. elegans 
Numerous studies have helped establish and characterize the anatomy of C. elegans 
(Brenner 1974; Byerly, Cassada et al. 1976; Sulston, Schierenberg et al. 1983). C. elegans goes 
through various larval stages before becoming an adult. Its long unsegmented body is cylindrical 
and divided into an outer and an inner layer separated by a pseudocoelomic cavity. The nervous 
system, muscular system, excretory system, cuticles and hypodermis are found in the outer layer; 
while the inner layer consists of the pharynx, intestine and gonads. The whole body is 
osmotically regulated by cells of the excretory system located in the posterior end.  
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Figure 1 Anatomy of C. elegans.  
A) An adult worm and two eggs. B) An adult worm showing various anatomical regions. 
(www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro) 
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Figure 2. Cross sections of the C. elegans. 
Figures A, B, C, D & E show cross sections of the worm at different locations. Pseudocoelomic 
cavity is seen in Fig A, separating the outer and the inner layer. Fig B, C and D show cross 
sections in the anterior, middle and the posterior ends of the head region. Fig E shows cross 
section of the body displaying dorsal and ventral nerve cords (DNC and VNC). Fig F shows 
section of rectum. 
(www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro) 
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 The hypodermis produces cuticle which comprises the outer layer. The nervous system 
consists of ganglia that are mostly concentrated around the pharynx in the head. They are also 
located in the mid-region of the body. The epithelial and the nervous system are separated by a 
basal lamina. Motor neuron signals influencing muscular movements are received by the 
muscular arms that come in contact with the nerve cords present in the nerve ring. The excretory 
system is involved in the expulsion of the waste from the body of the worm. 
 The pharynx of C. elegans functions independently and has its own muscular and nervous 
system. It is an organ that in involved in ingestion of food, and in passing the ground food to the 
intestine through an intestinal valve which connects to the intestinal lumen. Once inside the 
intestine the nutrients are absorbed by the microvilli that line the apical surface of the tubular 
intestinal lumen. The lumen is made up of 20 cells that have originated from a single somatic E 
blast cell lineage of cells. The cells that make the intestine are the only somatic tissue derived 
cells in C. elegans. The waste is then excreted out through the rectum, which is connected to the 
gut through a rectal valve. 
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Figure 3. Reproductive system of C. elegans 
(www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro) 
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Reproductive system of C. elegans 
 Somatic gonad, germ line, and the egg-laying apparatus comprise the three key parts of 
the reproductive system. The somatic gonad and the germ line form two U-shaped gonad arms 
that are connected by a uterus. Distal tip cell (DTC), gonadal sheath, spermatheca (sp), and a 
spermatheca-uterine (sp) valve together make up the somatic gonad which is distal to proximal in 
its organization (Fig 3). As the germ cells in the distal end, that are only mitotic in nature, move 
towards the proximal end, they enter the prophase stage of meiosis and reaches pachytene stage 
thus becoming differentiated in the proximal gonad. The hermaphroditic worms first produce 
sperm in the spermatheca before switching to a female somatic oocyte production. Self-
fertilization of the female gametes by the sperm in the spermatheca roughly produces 300 
embryos which move into the uterus, before the eggs are laid through an opening called the 
vulva. 
Life cycle of C. elegans 
There are two sexes in C. elegans, the predominant of which are the hermaphrodites 
(XX). Males (XO) comprise only 0.1% of the population and are generated as a result of an 
occasional non-disjunction in the germline of the hermaphrodites. However, hermaphrodites to 
high temperatures can increase the rate of male population generation to about 50%. Also mating 
between hermaphrodites and males can produce mutant offspring that can be stored at very low 
freezing temperatures. Under normal conditions, the worms possess a life span of approximately 
3 weeks, but they can survive adverse environmental conditions by switching to a different 
lifestyle called the dauer stage. The dauer stage is facultative diapause stage which helps the 
worms survive longer than normal, increasing their life span 3 to 8 times that of their normal 3-
week period. 
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 The life cycle of C. elegans starts with the embryonic stage and proceeds to four larval 
stages (L1-L4) before attaining adulthood. The end of each larval stage is marked by a molt 
during which the cuticle of the previous larva is shed and a new one is synthesized. The first step 
of molting is the separation of the cuticle from the hypodermis (apolysis), the next step is the 
synthesis of a new cuticle, and the last step is the shedding of the old cuticle (ecdysis). The 
proteins synthesized during these ‘molt’ stages are stage specific and their production is higher in 
comparison to the non-molting stages. The microscopic structure of the cuticle varies during 
different stages. Prior to apolysis, pharyngeal pumping stops and the worm enters a stage of 
dormancy or immobility. This immobile or lethargus stage is divided into two phases. During the 
first phase, the cuticle begins to loosen around the rear end, the lips and the buccal cavity. The 
second phase is marked by further loosening of the cuticle from the body; the worm turns and 
flips longitudinally around on its axis. As the cuticle breaks down on both the posterior end on 
the intestinal side and at the dorsal end of the mouth, the larva forces itself out of a hole made 
near the head region.  
 The first cleavage of the embryo happens 40 min after fertilization and the eggs are laid 
150 min after fertilization while still in gastrula stage. The larva that emerges goes through many 
different stages becoming a full grown adult as can be seen in Fig 4. 
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Larva 1 
Five classes of motor neurons (VAn, VBn, VCn, ASn, VDn) are generated by the end of 
the L1 larval stage development. These 5 classes are produced from 13 precursors, W and P1-
P13 (Sulston and Brenner 1974; Sulston and Horvitz 1977; Chalfie and White 1988). Also a 
ventral cord neuron (DDn) proceeds through the presynaptic phase which is inhibitory to the 
ventral wall muscles but is postsynaptic in its effect on the dorsal wall-activating neurons. 
Another class of motor neurons called VD motor neurons is generated during late L1 phase. At 
this point the DD motor neurons reverse in their function and become inhibitory to the dorsal 
muscle walls while being postsynaptic on the active neurons of the ventral wall muscles (White, 
Albertson et al. 1978; Walthall, Li et al. 1993). 
 In hermaphrodite worms, the two somatic gonad precursors Z1 and Z4 produce 12 cells, 
while the germline precursors Z2 and Z4 begin their long-lasting division that will continue to 
their adulthood (Kimble and Hirsh 1979). 
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Figure 4. Life cycle of C. elegans. The different molting stages that a worm undergoes 
before attaining adulthood are shown in the figure. 
(www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro) 
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L2 larva and dauer (L2d) larva 
There is limited division during the L2 stage.  Germline cells types Z2 and Z3 continue 
division resulting in quadruples. There is very little change in the Z1 and Z4 types. The somatic 
and germline lineages are basically interconnected until the stage of the L2/L3 molt is reached 
when there is a separation that leads to the formation of distal tip cell (DTC) and other gonadal 
structures. 
 The initial signal for the emergence of a dauer larva occurs in the middle of the L1 stage. 
Dauer stage larva will develop at the end of L2 stage if conditions are unfavorable. High 
temperatures, scarcity of food, and pheromones secreted during over-crowding of animals are 
factors known to induce the dauer stage. Under these conditions the worm does not molt into L3 
but remains dormant, thickens it cuticle, shortens in size, stops feeding, ceases to move and does 
not age. Also there is shrinkage of the intestinal and pharyngeal lumen, a blockade of the buccal 
cavity by the cuticle and the complete lack of secretion by the granular glands of the excretory 
system. Gut cells turn dark and some microvilli appear in the intestine. As a result, entrance into 
a L3 stage under favorable conditions the normal life span is unaffected. When the dauer state is 
exited, feeding begins in about 3 hours and in about 10 hours, the worm molts into the L4 stage. 
L3, L4 and the adult 
The spermatheca and uterus develop from the somatic gonad precursors (total of 143 
cells) in the L3 and the first part of the L4 stage (Kimble and Hirsh 1979). During L3, the growth 
of the distal tip cell (DTC) realigns and diverts in the dorsal direction. The vulva begins to 
develop from its precursors and vulval terminal cells develop by the early L4 stage.  
 The L3/L4 molt is characterized by germline meiosis producing sperm. Sperm 
development stops at the L4/adult molt during which the remaining germline cells differentiate 
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into oocytes. Egg-laying apparatus takes shape by a coordinated association of the vulval and 
uterus terminal cell generation, egg-laying neurons, and sex muscles. 
 An adult develops about 2 days after hatching, completing a reproductive cycle that lasts 
a total of 3 days (Byerly, Cassada et al. 1976). Oocytes are produced for about 4 days by the 
adult worm which can then continue to live for another 15 days. Each adult can lay up to 300 
eggs.  
Cholesterol and C .elegans 
C. elegans does not possess cholesterol synthesizing enzymes and hence are auxotrophic 
for cholesterol (Hieb and Rothstein 1968; Chitwood and Lusby 1991). In the wild, they acquire 
cholesterol from animal feces and plant remnants.  In the laboratory, they are provided with 
cholesterol in the nematode growth medium (NGM). As in other animal cells, cholesterol plays 
an essential role in the organization of the plasma membrane of nematodes. Inefficient molting 
and other defects in the reproductive cycle have been observed among worms grown in 
cholesterol-free medium (Yochem, Tuck et al. 1999).  Cholesterol deprived worms have also 
been shown to display acceleration in their meiotic cell division by exiting the pachytene arrest, 
which is under the regulation of the Ras/MAP-kinase pathway (Church, Guan et al. 1995). 
The mode of cholesterol uptake by the worms is not well understood. Whether its uptake 
is by the cuticle or the gut is still under investigation. The molecules involved in transporting 
cholesterol to various organs inside the worm have not been characterized, though 
gp330/megalin, belonging to the low-density lipoprotein (LDL) receptor superfamily is 
associated with this function (Yochem, Tuck et al. 1999). But its relatively high concentration in 
the hypodermis questions its role in the cholesterol absorption by the gut. A naturally occurring 
analog of cholesterol is a compound called dehydroergosterol (DHE) which possesses almost 
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identical activities as cholesterol (Schroeder, Jefferson et al. 1991; Schroeder, Woodford et al. 
1995) and has been used to study the transport of cholesterol in these transparent worms using 
fluorescent microscopy. However, because of the inflexibility in its UV absorption and emission, 
it turned out to be a less successful candidate for the study than predicted. Cholesterol binding 
proteins have recently been studied with ease using a biologically active radiolabeled [
3
H] 
photocholesterol. The use of DHE and [
3
H] photocholesterol accumulation in C. elegans has 
primarily been found in the oocytes and the developing sperm (Matyash, Geier et al. 2001) . This 
stresses the importance of high level cholesterol storage in the oocytes for the growth and 
development of the embryo. However, the cholesterol level of sperm wanes in comparison with 
that of oocytes suggesting that the level of cholesterol in the sperm is insignificant for the 
development of the embryo.  
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Pathogen susceptibility in C. elegans 
C. elegans displays diverse behaviors in the presence of bacteria. While some bacteria 
serve as its food, others can be pathogenic to these worms and induce activation of the innate 
immune system pathways to fight the pathogens. Studies using two different strains of worms to 
compare their behavior in response to pathogen exposure using Pseudomonas aeruginosa have 
shown that the N2 strain (isolated in Bristol, England) of worms took longer (90±13 hours) than 
another strain CB4856 (50±7.8 hours) in its susceptibility towards Pseudomonas aeruginosa for 
50% lethality (Reddy, Andersen et al. 2009).  A G-protein coupled receptor encoding gene npr-I 
is associated in the susceptibilities of these two strains. This receptor is closely related to the 
neuropeptide Y receptor of mammals. The N2 strain showed increased npr-I activity as 
compared to strain CB4856. This increased npr-I activity, caused by a polymorphism in its npr-I 
gene, is suggested to be responsible for the better pathogen fighting ability of the N2 strains 
(Reddy, Andersen et al. 2009).  
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CHAPTER 2 
 
MATERIALS AND METHODS 
Bacterial strains 
S. aureus strains including MSSA476, MW2 and Newman were procured from the 
network on antimicrobial resistance in Staphylococcus aureus (NARSA), Eurofins Medinet, 
Virginia, USA. Micrococcus luteus, Pseudomonas aeruginosa, and Proteus vulgaris were 
purchased from American Type Culture Collection (ATCC). Glycerol stock cultures were made 
by adding 200µl of 80% glycerol to 800µl of overnight cultures of bacteria grown in tryptic soy 
broth (Difco). Stocks were stored at -70ºC. Before performing a bioassay, overnight cultures 
were prepared by inoculating a loopful of the glycerol stock into 3 ml Tryptic soy broth (Difco) 
and incubated at 37ºC. 
Genomic DNA extraction and purification from S. aureus MSSA476 
Overnight cultures of MSSA476 were used for DNA extraction using Invitrogen Pure 
Link Genomic DNA kit. All buffers and reagents were from the kit. Overnight cells were 
harvested by centrifugation at 10,000 x g for 2 min, and the pellet obtained was resuspended in 
180µl of the lysozyme digestion buffer, which was incubated at 37ºC for 30 min after vortexing 
for 2 sec. To this, 20 µl proteinase K and 200 µl genomic lysis/binding buffers were added, 
mixed and incubated at 55ºC for 30 min. This was followed by addition of 96-100% ethanol to 
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the lysate and the mixture was vortexed to obtain a homogeneous solution. Purification of the 
extracted DNA was carried out by adding the lysate to the spin column and centrifuged at 10,000 
x g for 1 min. After discarding the filtrate from the collection tube, the spin column was replaced 
and centrifuged for 1 min at 10,000 x g after adding 500 µl of wash buffer. The filtrate was 
discarded, 500 µl wash buffer 2 was added and the centrifugation was repeated at 16,000 x g for 
3 min. The spin column was removed and placed over a sterile microcentrifuge vial. Pure Link 
Genomic elution buffer (25-200 µl) was added to the column and incubated for 1 min at room 
temperature. The purified DNA was collected in the microcentrifuge vial. 
PCR 
Primers were designed using the Invitrogen primer design tool for Gateway cloning 
which simulates the recombination that occurs in nature between the lambda bacteriophage and 
the E. coli genome (Zinn, Mellon et al. 1982; Bushman, Thompson et al. 1985; Landy 1989). 
Both the forward and reverse primers were designed to carry, at their 5’ ends, a 25 base pair 
sequence known as attachment sites attB1 and attB2 (Weisberg and Landy 1983) . These att sites 
were stabilized by further adding four guanine residues on their 5’ ends. The att sites are sites of 
attachment for various recombination proteins during recombination. The attB1 and attB2 sites 
recombine with attP1 and attP2 sites on the donor vector before inserting the gene of interest 
(Hartley, Temple et al. 2000). In order to fuse SAS1738 to a 6x His tag sequence, the stop codon 
was excluded in the reverse primer. However, there is a stop codon on the expression vector 
immediately after the 6x His tag sequence.  
 PCR was performed using a Promega kit, and as per Promega’s protocol. The 50 µl 
reaction volume consisting of 8 µl MgCl2, 10 µl 5X GoTaq buffer, 2 µl PCR nucleotide mixture, 
0.25 µl each of the forward and reverse primer to a concentration of 0.5 µM , 0.25 µl of GoTaq 
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DNA polymerase, 1 µl purified DNA template (approximately 0.5 µg per 50 µl) and 28.25 µl 
distilled water. Primer sequences and PCR program parameters are given in Table 1. 
 PCR amplification was confirmed by performing a 1% agarose gel electrophoresis 
(Laemmli 1970). Agarose gel (1%) was prepared by adding 0.3 g agarose (Fisher Scientific) to 
30 ml 1X TAE buffer (40 mM Tris-acetate and 1 mM EDTA, pH 8.3 at 25ºC). The mixture was 
heated in a microwave for about 50 sec until the agarose melted and the solution was 
homogeneous. The hot solution was poured into a gel block with both of its open ends sealed 
with tape. A comb of appropriate length was inserted in the gel 1 mm from the base to make 
wells. After solidification of the gel, the comb was gently removed and the tape was removed. 
The gel was placed along with the block inside a chamber and was filled with 1X TAE buffer 
sufficient to cover the top of the gel. 5 µl of 1 Kb DNA marker (Invitrogen) was loaded into a 
well for size comparison. PCR reaction mixture (3 µl), previously mixed with GoTaq green gel 
loading buffer was loaded into a well. Electrophoresis was carried out at 100 volts (constant 
voltage) for about 45 min until the dye was approximately 0.5 cm from the bottom of the gel. 
The gel was transferred to a UV transilluminator and the amplified bands were observed. The 
amplified band corresponded to about 0.6 Kb lengths because of the addition of att B sites. 
The amplified PCR product carrying the att B sequences were purified from the PCR reaction 
mixture by adding 150 µl of TE buffer (10 mM Tris-HCl/1 mM EDTA buffer, pH 8.0) and 100 
µl of 30% PEG 8000/30 mM MgCl2 to the 50 µl PCR reaction mixture. The vial was mixed well 
using a vortex and centrifuged for 15 min at 10,000 x g. The supernatant was removed and the 
pellet was dissolved in 50 µl of TE, pH 8.0. The amount of the PCR amplified DNA to be used 
in the first step of cloning (the BP reaction) was determined by the formula (50 fmol) x (N) x 
(660 fg/fmol) x (1 ng/10
6
 fg) where N is the size of the amplified fragment; the size of the 
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amplified product was 639 bp (564 bp was the gene of interest, 50 bp was the att B sites, 8 bp 
was the guanine residues and 17 bp was from the sequence upstream of the gene of interest that 
includes the ribosome binding site). From the formula 21.087 ng/µl of the amplified DNA was 
needed for BP reaction. The concentration obtained from the fluorometer reading was 11 ng/µl. 
Therefore, 2 µl of the PCR amplified DNA was used for BP reaction. 
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Table 1.  
Oligonucleotides and program settings used in PCR 
Primer sequences 
The attachment sites are shown in bold. 
 
Forward 
5’GGGGACAAGTTTGTACAAAAAAG
CAGGCTCCAAAGGAGCAATAAAAAT
GAATAC 3’ 
 
Reverse 
5’GGGGACCACTTTGTACAAGAAAG
CTGGGTCATCAATTGTGATTTTGTTG
AT 3’ 
 
PCR program parameters 
1) 95ºC – 2 min 
2) 94ºC – 50 sec 
3) 55ºC – 50 sec 
4) 68ºC – 90 sec 
5) Cycle 5x to 2 
6) 95ºC – 30 sec 
7) 55ºC – 30 sec 
8) 72ºC – 90 sec 
9) Cycle 25x to 6 
10) 72ºC – 5 min 
11) 4ºC – 0 min (END) 
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Cloning and Expression of SAS1738 
Cloning was performed using Invitrogen Gateway Cloning Technology, which uses a 
site-specific recombination feature found in bacteriophage lambda (Zinn, Mellon et al. 1982; 
Bushman, Thompson et al. 1985; Landy 1989). This technique involves cloning of the gene in 
two separate steps called the BP and LR recombination reactions. 
The BP reaction involves recombination between the attB PCR product and the attP 
sequence bearing donor vector, pDONR
TM
 221, from Invitrogen 
The reaction was carried out in a microcentrifuge vial containing 2 µl PCR product, 1 µl 
donor vector, 5 µl TE buffer at pH 8.0. To this mixture, 2 µl BP clonase II was added and the 
vial was incubated at 25ºC overnight. Following incubation, 1 µl of proteinase K was added to 
the vial and was incubated for another 10 min at 37ºC, to remove the enzymes from the mixture. 
The recombination products are the entry clones (Fig1) that have the gene of interest flanked by 
attL1 and attL2 sites on either end inserted in place of chloramphenicol and ccdB resistance 
genes thus knocking out both (Bushman, Thompson et al. 1985; Landy 1989). 
 The entry clones generated after the BP recombination reaction were transformed into 
One Shot OmniMAX 2-T1 chemically competent E. coli (Invitrogen) cells that were CcdB 
protein resistant (Bernard and Couturier 1992; Miki, Park et al. 1992; Bernard, Kezdy et al. 
1993) by first thawing the vial on ice, adding 2 µl of the BP reaction mixture and incubating on 
ice for 30 min. The cells were subjected to heat shock by placing the vial at 42ºC for 30 sec and 
immediately replacing it in ice. SOC medium (250 µl), kept at room temperature, was added and 
the vial incubated at 37ºC for 1 hour in a shaker incubator set to 225 rpm. After a 1:10 dilution of 
the transformation mixture in Luria Bertoni (LB) broth, 20 µl and 100 µl were spread on LB agar 
plates containing 50 µg/ml kanamycin and incubated overnight at 37ºC. Five colonies were 
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individually picked for the successful insertion of the gene of interest. Screening was done by 
inoculating the five colonies into separate vials containing 50 µl PCR mixtures, except this time 
it contained an additional 1 µl of distilled water to substitute for 1 µl DNA template not used in 
this reaction. After PCR, a 1% agarose gel showed the bands corresponding to the fragment of 
interest (639 bp). Also the five colonies were streaked on chloramphenicol containing LB agar 
plates and none of the colonies grew, indicating that they were true transformants. The five 
colonies were grown in LB broth containing 50 µg/ml kanamycin and the entry clone plasmids 
were extracted using Zymoclean plasmid miniprep kit. The purified plasmid was used for the 
next cloning stage to obtain expression clones (the LR reaction). 
The LR reaction involves recombination between the entry clones with attL sites and the 
destination vector pET-DEST42 (Invitrogen) carrying attR sites 
The entry clones (50-150 ng/µl) were used in the second recombination reaction with the 
destination vector pET-DEST42 containing a C-terminal 6x His tag. The reaction was carried out 
in a vial containing 5 µl of the entry clone from the BP reaction, 1 µl of the pET-DEST42 
(150ng/µl), and 2 µl TE buffer, pH 8.0. To this mixture LR clonase II enzyme (Invitrogen) was 
added and the vial was incubated overnight at 25ºC. This was followed by addition of 1 µl 
Proteinase K and incubation for an additional 10 min at 37ºC. This reaction was catalyzed by the 
LR Clonase enzyme II (Invitrogen) which catalyzes recombination between the att L and att R 
sites of the entry clone and pET-DEST42 vector. The expression clone obtained after the 
reaction bears attB sites on either end of the gene of interest. The expression of SAS1738 will be 
mediated by the Lac operon and the T7 promoter present upstream of the gene of interest. 
SAS1738 will be expressed as a fusion protein bound to a C-terminal V5 epitope and 6x His 
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sequence, so that the expressed protein can be either purified using Histidine binding Nickel or 
Cobalt columns or can be detected using anti-V5 antibodies. 
 The expression clones generated after the LR recombination reaction were transformed into 
One Shot OmniMAX 2-T1 chemically competent E. coli (Invitrogen) cells as described above, 
but using the LR reaction mixture. The clones were screened using LB agar plates containing 
100 µg/ml ampicillin. Five colonies were individually picked for the successful insertion of the 
gene of interest. Screening was done by inoculating the five colonies into separate vials 
containing 50 µl PCR mixtures, except this time it contained an additional 1 µl of distilled water 
to substitute for 1 µl DNA template not used in this reaction. The resulting colonies were 
subjected to PCR as described above and agarose gel electrophoresis was used to visualize the 
resultant PCR product. Electrophoresis showed bands corresponding to the fragment of interest 
(639 bp). Also the five colonies were grown in LB broth containing 100 µg/ml ampicillin and the 
expression clone plasmids were extracted using Zymoclean plasmid miniprep kit. The purified 
plasmid was used for the next transformation step with E. coli BL21-AI One Shot
®
 competent 
cells. 
Transformation and protein expression in E. coli BL21-AI One Shot
®
 competent cells 
The expression clones were transformed into E. coli BL21-AI One Shot
®
 competent cells 
that were derived from the BL21 group of expression cells (Studier and Moffatt 1986; Grodberg 
and Dunn 1988). Transformation was carried out by the same procedure as described above. E. 
coli BL21-AI One Shot
®
 competent cells have a T7 RNA polymerase gene in the araB locus of 
the araBAD operon. The araB is replaced by the T7 RNA polymerase gene which in turn is 
regulated by the araBAD promoter. Hence, to induce expression L-arabinose was added (Lee, 
Butler et al. 1987).  
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Protein expression 
Five colonies were individually picked for the successful insertion of the gene of interest. 
Screening was done by inoculating the five colonies into separate vials containing 50 µl PCR 
mixtures, except this time it contained an additional 1 µl of distilled water to substitute for 1 µl 
DNA template not used in this reaction. After screening of colonies from ampicillin plates and 
confirming the successful insertion of the gene of interest, a single transformed colony forming 
unit was inoculated into 5 ml LB broth containing 100 µg/ml ampicillin and incubated at 37ºC 
overnight or until the OD600 was between 0.6-1.0. A 1:20 dilution (OD600=0.05-0.1) of this 
culture was made using LB broth with 100 µg/ml ampicillin and was incubated in a shaker 
incubator at 37ºC for about 2 hours until the mid-log phase OD600 reached ~ 0.4. The mid-log 
phase culture was divided into two equal parts containing 10 ml each, one to be induced, and the 
other an un-induced control. To one tube L-arabinose and IPTG were added to give final 
concentrations of 0.2% arabinose and 1 mM IPTG, respectively. To the other tube glucose was 
added to a final concentration of 0.1% in order to repress basal level expression of SAS1738 
(Miyada, Stoltzfus et al. 1984; Lee, Francklyn et al. 1987). A 1 ml sample from each tube was 
aliquoted into fresh sterile microcentrifuge vials every hour from the start of induction and 
placed in the -20
o
C freezer to stop induction. Samples were collected for four hours (Sambrook 
and Gething 1989).  
15% Sodium dodecyl sulfate-Polyacrylamide gel (SDS-PAGE) electrophoresis and 
Western Blot 
Two gels, each comprised of 10 ml resolving gel and 5 ml stacking gel, were prepared. 
One was for staining with Coomassie brilliant blue and the other for Western Blot. 
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SDS-PAGE gels were prepared as per the procedure described by Laemmli (Laemmli 
1970). The resolving gel (10 ml) consisted on the following: 2.5 ml 1.5 M Tris-HCl (pH 8.8) 
buffer, 4.33 ml acrylamide/bisacrylamide (30%/0.8% w/v), 100 µl 10% SDS, 3 ml distilled 
water, 50 µl  10% ammonium persulfate and 10 µl TEMED. Stacking gel (4%) consisted of the 
following components: 670 µl acrylamide/bisacrylamide (30%/0.8% w/v), 1.25 ml 0.5 M Tris-
HCl (pH 6.8) buffer, 50 µl 10% SDS, 3 ml distilled water, 25 µl 10% ammonium persulfate, and 
10 µl TEMED. 
Tank buffer was prepared using the following method: to prepare a total volume of 2000 
ml, 28.8 g glycine, 6 g Tris base, and 20 ml 10% SDS were added to 1000 ml distilled water. 
After adjusting the pH to 8.3 with HCl, the volume was increased to 2000 ml with distilled 
water.  
The 10 ml of resolving gel were carefully added into the space created by two glass plates 
separated by spacers. The resolving gel was allowed to polymerize after which the stacking gel 
was prepared and poured onto the solidified resolving gel. An appropriate comb was inserted 
into the still liquid stacking gel and allowed to polymerize. The 1ml fractions collected from the 
un-induced and induced samples were centrifuged at 12,000 rpm (11,750 x g) for 1 min. After 
discarding the supernatant, the pellet was resuspended in 100 µl of 1X SDS treatment buffer and 
the mixtures were heated to 90ºC for 10 min to denature the proteins. The mixture was cooled to 
room temperature and centrifuged at 9,000 rpm (6,610 x g) for 5 min. Samples (15 µl)  from 
induced and un-induced reactions were loaded onto the SDS-PAGE gel. A 5 µl aliquot of protein 
standard marker sample (14,000 - 66,000) was loaded for comparison. The gel was placed in the 
tank buffer and electrophoresis was carried out at 150 V (constant voltage) for ~ 1 hour. One gel 
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was stained with Coomassie brilliant blue overnight followed by destaining with methanol/acetic 
acid while the other was used for Western blot. 
Novagen His bind® AP Western reagents kit was used to perform Western blot 
 Blocking solution (3% bovine serum albumin (BSA) was prepared fresh in 1X Tris buffered 
saline (TBST) (150 mM NaCl, 10mM Tris-HCl (pH 7.5), 0.1% Tween-20) by adding 3 g of BSA 
to 100 ml of 1X TBST. Two liters of transfer buffer were prepared by dissolving 7.25 g Tris-
Base and 33.5 g glycine in 1000 ml distilled water. Methanol (600 ml) was added to the mixture 
before the volume was brought to 3 L with distilled water after adjusting the pH to 8.0. 
 A Bio-Rad transblot system was used to perform Western blot as per the nitrocellulose gel 
transfer procedure of Towbin (Towbin, Staehelin et al. 1992). The SDS gel that was not 
subjected to Coomassie blue staining was placed on a nitrocellulose membrane and sandwiched 
in Whatman filter paper. This sandwich was again sandwiched between two pieces of sponge, 
clamped and placed in the Western Blot apparatus. The entire setup was then immersed in SDS 
tank buffer and protein transfer was carried out electrophoretically at 100 milliamps (constant 
current) overnight. The current was increased to 200 milliamps for another hour the following 
day. The nitrocellulose membrane was carefully removed and subjected to a series of washing 
and blocking steps as follows: two 10 min washes with 15 ml 1X TBS (150 mM NaCl, 10 mM 
Tris-HCl, pH 7.5), 1 hr incubation in 15 ml blocking solution at room temperature, two 10 min 
washes with 20 ml TBSTT (1X TBS, 0.05% Tween-20, 0.2% Triton X-100), a 10 min wash with 
1X TBS, 1 hr incubation in 10 ml of 1:1000 dilution of  anti-His monoclonal antibody prepared 
by adding 10 µl of antibody (Invitrogen) to 10 ml of blocking solution, two 10 min washes with 
20 ml 1X TBSTT, a 10 min wash with 15 ml TBS, 1 hr incubation with 8 ml 1:5000 dilution of 
goat anti-mouse IgG antibody conjugate prepared in blocking solution, and five 10 min washes 
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with 20 ml 1X TBSTT. All washing and binding steps were carried out with gentle rocking on a 
shaker. The membrane was transferred to a clean container and the developing solutions were 
added. Glycerol stocks of colonies that were deemed positive by the Western Blot were prepared 
and stored at -70ºC for further use. 
Protein purification was carried out as per a Novagen protocol for His-bind purification 
kit  
Overnight cultures were prepared by inoculating a loopful of glycerol stock from -70ºC 
into LB broth containing 100 µg/ml ampicillin. A 1:20 dilution (OD600=0.05-0.1) of this culture 
was made using LB broth with 100 µg/ml ampicillin (total volume 400 ml) and was incubated in 
a shaker incubator at 37ºC for about 2 hours until the mid-log phase (OD600 ~ 0.4). This mid-log 
phase culture was divided into two equal parts containing 200 ml each, one to be induced and the 
other an un-induced control. To one part, L-arabinose and IPTG were added to give final 
concentrations of 0.2% arabinose and 1 mM IPTG, respectively, for induction. To the other un-
induced control, glucose was added to a final concentration of 0.1% to repress basal level 
expression of SAS1738. Both samples were incubated for 4 hours at 37ºC with constant shaking 
at 200 rpm (Miyada, Stoltzfus et al. 1984; Lee, Francklyn et al. 1987). The cells were harvested 
by centrifuging at 10,000 x g for 10 min. The supernatant was discarded and the pellet was 
drained completely by tapping the container on a tissue. To the pellet, 80 ml 1X binding buffer 
(40 ml per 100 ml culture volume) was added. The samples were briefly sonicated for 
resuspension and centrifuged for 15 min at 5,000 x g. The supernatant was discarded and the 
pellet was resuspended in 40 ml 1X binding buffer (20 ml per 100 ml culture volume). The 
samples were sonicated for three 6 min cycles at a constant duty cycle of 30% to release trapped 
proteins. After centrifugation at 5000 x g for 15 min, the pellet was resuspended in 10 ml (5 ml 
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per 100 ml culture volume) 1X binding buffer containing 6 M guanidine-HCl. This was followed 
by incubation on ice for 1 hr and centrifugation at 16,000 x g for 30 min. The supernatant from 
both samples was used for the purification process by column chromatography.  
Column preparation   
Two Novagen chromatography columns were prepared for the induced and un-induced 
samples. Sterile distilled water was added to the dry column and by pushing the column top with 
the gloved finger proper flowing through the column was ensured. His-Bind resin present in the 
form of slurry was mixed by inverting the container and 1 ml was pipetted into the column, 
resulting in 0.5 ml of a settled bed volume of resin. The resin was allowed to pack under gravity 
flow of storage buffer. When the storage buffer was almost gone, the following washes were 
carried out to charge the resin and maintain equilibration: 3 volumes (1.5 ml) of sterile distilled 
water, 5 volumes 1X charge buffer ((50mM NiSO4) (2.5 ml)) and 3 volumes 1X binding buffer 
((0.5 M NaCl, 20 mM Tris-HCl, 5 mM imidazole, pH 7.9)(1.5 ml). 
Column chromatography 
After 1X binding buffer was drained to the top of column bed, the 10-ml samples were 
loaded into the column, followed by a series of washes  carried out with 10 volumes  (5 ml) 1X 
binding buffer and 6 volumes (3 ml) 1X wash buffer (0.5 M NaCl, 60 mM imidazole, 20 mM 
Tris-HCl (pH 7.9)). The bound protein was eluted by adding 6 volumes (3 ml) 1X elute buffer (1 
M imidazole, 0.5 M NaCl, 20 mM Tris-HCl (pH 7.9)), and the eluate was collected as 1 ml 
fractions. 
Dialysis  
Eluate fractions from both the induced and un-induced samples were subjected to dialysis 
to separate the recombinant protein from salts and imidazole. Dialysis was carried out using 
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porous membrane tubing (Spectra/Por) with the molecular weight cutoff (MWCO) of 12,000-
14,000 daltons. Two 1.5 hour buffer changes were carried out before the setup was left for 
overnight dialysis with constant stirring at 4ºC. After dialysis, the samples were carefully 
removed by unclamping one end of the tubing and letting the sample flow into a sterile micro-
centrifuge tube. The collected samples were concentrated using Centriplus YM 3 concentrators 
(Millipore) by centrifuging at 3000 x g for 1 hour. The concentrated sample from the retention 
vial was collected and filtered through a sterile 0.22 µm membrane filter to remove any bacterial 
contaminants. 
Bioassays for antibacterial activity  
Overnight cultures of bacteria were produced by inoculating 5 ml tryptic soy broth 
(Difco) with aliquots from 80% glycerol freezer stocks and incubating at 37ºC. The cultures were 
diluted with sterile tryptic soy broth (Difco) to match a 0.5 MacFarland turbidity standard. 
Bacterial lawns were prepared using the diluted cultures on Mueller-Hinton agar (Difco) plates. 
The plates were divided so that one half was tested with un-induced sample and the other with 
induced sample. 10 µl purified protein samples (~ 50 µg/ml) from induced and un-induced 
cultures were dispensed onto the lawns, respectively. The plates were incubated at 37ºC 
overnight. 
Preparation of nematode growth media (NGM) and seeding of NGM with E. coli OP50   
The N2 strain of C. elegans was purchased from University of Minnesota C. elegans 
Genomic Center (CGC). The worms were maintained on E. coli OP50, a pure culture of which 
was obtained from CGC.  
 NGM plates were prepared by adding 3 g NaCl, 2.5 g peptone and 17 g agar to 975 ml 
distilled water. This mixture was autoclaved at 121
0
C for 50 min and cooled to about 55
0
C. To 
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this cooled solution, the following sterile solutions were added and shaken to mix well: 1 ml (1 
M) CaCl2, 1 ml (5 mg/ml) cholesterol in ethanol, 1 ml (1 M) MgSO4, and 25 ml (1 M) KPO4 
buffer (pH 6)  (108.3 g KH 2PO4, 35.6 g K2HPO4,  H2O to 1 liter) . This NGM agar medium in its 
molten state was poured into sterile Petri plates and allowed to solidify at room temperature 
(Brenner 1974). The plates were held at room temperature for 2 days to ensure no contamination. 
A fresh overnight culture of E. coli OP50 was used to seed the NGM plates (Hirsh, Oppenheim 
et al. 1976). The overnight E .coli OP50 culture (50 µl) was spread on the center of the NGM 
plate with a sterile loop to obtain a circular lawn of about 60 mm diameter. The seeded plates 
were allowed to incubate at room temperature overnight.  
 Platinum wire bent in the shape of a hook and attached to the holder of an inoculating 
needle was used for the transfer of worms.  The surface and tip of the wire were flattened with a 
heavy rod and the edges were rubbed with sand paper to remove sharpness to avoid inflicting 
injury to the worms. The individual worms were gently transferred to the E. coli OP50 lawn 
using a dissection microscope. Plates stored at 16
0
C can be stored longer than those kept at 20
0
C. 
However, the growth rate is 1.3 times faster at 20
0
C than at 16
0
C; plates were routinely incubated 
at 20
o
C (Maniatis 1982). 
Freezing of C. elegans for long term use 
 The method used for storage of C. elegans was provided by CGC and uses a soft agar 
freezing solution to store stocks at -80
0
C. This method allows for easy recovery of worms by 
inoculating a loopful of the frozen stocks onto a fresh plate.   Freshly starved L1 and L2 larvae 
are the stages of worms that survive the best at -80
0
 C (Brenner 1974).   
 Soft agar freezing solution was made by adding 0.58 g NaCl, 0.68 g KH2PO4, 30 g 
glycerol, and 0.56 ml 1 M NaOH, and 0.4 g agar to distilled water sufficient to bring the volume 
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to 100 ml (Avery 1993). The solution was mixed and autoclaved at 121
0
 C for 20 min and cooled 
to about 55
0 
C.  
 NGM plates containing freshly starved L1 and L2 larvae were obtained by letting the 
NGM plate with worms sit at room temperature until the E. coli OP50 was exhausted. This 
provides a great number of the L1 and L2 larvae for long-term storage. Each plate was washed 
with 600 µl of S buffer (129 ml 0.05 M K2HPO4, 871 ml 0.05 M KH2PO4, 5.85 g NaCl), the 
washings were collected in a sterile test tube and kept on ice for 15 min. An equal volume (600 
µl) of soft agar freezing solution that was held in a water bath maintained at 55
0
C was added to 
the test tubes. The test tube contents were then mixed well and 1 ml from this homogeneous 
solution was dispensed under aseptic conditions into sterile cryovials of approximately 2 ml 
capacity.  The cryovials were stored in a -80
0
C freezer for future use.   
Toxicity and behavior assay of C. elegans as a model host during treatment with SAS1738  
Two sets of NGM plates were prepared. To one set of plates 0.2% arabinose and 1 mM 
IPTG were added for induction. To the other set of plates glucose was added to a final 
concentration of 0.1% in order to repress basal level expression of SAS1738. 
 Toxicity assays were performed by first growing overnight cultures of E. coli OP50 in 
LB broth and E. coli BL21-AI One Shot
® 
carrying the plasmid containing SAS1738 encoding 
gene fused to 6 X His in LB broth containing 100 mg/ml ampicillin. After overnight incubation 
both the E. coli OP50 and the E. coli BL21-AI One Shot
®
 were diluted 1:20 times with LB broth 
to an OD600 of 0.05-0.1. The diluted cultures were then incubated with constant shaking for about 
2 hours until the OD600 reached about 0.4 (mid-log phase). At this stage 50 µl culture from the E. 
coli OP50 tube was spread on a NGM plate containing no IPTG and arabinose to obtain a 
circular lawn. Another 50 µl was spread on a NGM plate containing 0.2% arabinose and 1 mM 
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IPTG. Likewise, circular lawns using 50 µl of E. coli BL21-AI One Shot
®
 grown to mid-log 
phase were obtained on NGM plates with and without arabinose and IPTG. The plates were 
incubated at room temperature overnight. The following day, 3 adult worms were transferred 
aseptically to each of the four plates under a dissection microscope. The plates were incubated at 
20
0
 C for 3-4 days and assessed by counting the number of worms in the treated, untreated, and 
control plates.  
GFP fusion to track SAS1738 inside C. elegans 
A pGFP plasmid vector purchased from Clonetech was used for GFP fusion studies. This 
vector was converted to a gateway cloning destination vector by using Invitrogen Gateway 
vector conversion kit system. Restriction digestion of about 5 µg of pGFP vector was carried out 
with SmaI enzyme which induced a single blunt ended cut in the 5’ MCS of the vector thus 
linearizing it to possess two blunt ends.  The 5’ phosphates were removed by using calf intestinal 
alkaline phosphatase (CIAP) to prevent self ligation by adding 4 µl of 10 x CIAP buffer, 1 pmol 
of DNA, 39 µl of sterile water, and 1 µl of CIAP into a 1.5 ml microcentrifuge vial and 
incubating at 50
0 
C for 1 hr. The mixture was then incubated at 65
0
C for 15 min to heat-
inactivate the CIAP.  
 Ligation reaction was carried out by adding 1-5 µl dephosphorylated DNA (20-50 ng), 2 
µl (5X) T4 DNA ligase buffer, 2 µl gateway reading frame cassette (10 ng) carrying the attR 
sites, 1 µl T4 DNA ligase (1 unit), and sterile water to a final volume of 10 µl. The mixture was 
incubated at 16
0
C overnight. 
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Figure 5. pGFP vector (Clontech) and pET-DEST42 vector (Invitrogen).  
SmaI restriction site on the 5’MCS of pGFP vector was nicked to linearize the vector for 
conversion to a destination vector with attR sites as described above. 
LR reaction between the entry clone carrying SAS1738 gene and the gateway 
destination vector carrying GFP gene (pDEST-GFP) and transformation of the same into 
E. coli BL21 A1 shot competent cells.  The LR reaction and transformations were performed as 
described above. The transformants were isolated and grown in LB for GFP-fused protein 
expression.  
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Feeding C. elegans with E. coli BL21 A1 shot cells expressing GFP-fused SAS1738  
GFP tracking of SAS1738 was carried out by first feeding to the worms bacteria expressing the 
protein.  
This assay was performed by first growing overnight cultures of E. coli OP50 in LB broth 
and E. coli BL21-AI One Shot
® 
 carrying the plasmid containing SAS1738 fused to GFP in LB 
broth containing 100 mg/ml ampicillin. After overnight incubation, both the E. coli OP50 and the 
E. coli BL21-AI One Shot
®
 were diluted 1:20 times with LB broth to an OD600 of 0.05-0.1. The 
diluted cultures were incubated with constant shaking for about 2 hrs until the OD600 reached 
about 0.4 (mid-log phase). At this stage 50 µl of E. coli OP50 culture was spread on a NGM 
plate containing no IPTG to obtain a circular lawn. Another 50 µl was spread on a NGM plate 
containing 1 mM IPTG. Likewise, circular lawns were produced using 50 µl of E. coli BL21-AI 
One Shot
®
 grown to mid-log with and without IPTG. The plates were incubated at room 
temperature overnight. The following day, 3 adult worms were transferred aseptically to each of 
these four plates under a dissection microscope. The plates were incubated at 20
0
 C for 3-4 days.  
Worms were picked individually from both the control and the test plates and observed under a 
fluorescence microscope after treating them with 3 % formaldehyde.  
Toxicity assay of C. elegans using purified SAS1738 
The purified, dialysed and filtered protein sample containing SAS1738 was used for this 
assay. On a clean and dry microscope glass slide 20 µl of the purified sample containing 
approximately 50 µg/ml of the protein SAS1728 was dispensed on one end. On the other of the 
slide, end an equal volume of the purified sample from the control uninduced culture was 
dispensed with a sterile micropipette. Adult C. elegans growing on E. coli OP50 were gently 
removed one at a time, with a bent metal wire under aseptic conditions. One worm each was 
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transferred into the 20 µl sample dispensed on both ends of the slide. The slide was constantly 
under observation with the naked eye. When the movement of the worm slowed down or 
stopped, the slide was placed under a compound microscope at 10 x magnification to ascertain 
the death of the worm by looking for lack of pharyngeal pumping action. A total of five trials 
were carried with each trial lasting for 60 min. The worms were transferred one at a time in order 
to make sure that there were no larval stages being transferred and also to reduce the chances of 
inflicting external physical harm during transfer, which would produce erratic experimental 
results.  
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CHAPTER 3 
 
RESULTS AND DISCUSSION 
The results obtained for individual experiments are reported in the order they were 
performed and the overall summary based on the antibacterial assay and C. elegans toxicity 
assay is discussed later.  
Result 
BP recombination  
The entry clones generated after BP recombination reaction (Fig 6) had SAS1738 
encoding gene inserted into the pDONR™ 221vector in place of the ccdB and CmR genes. The 
transformants failed to grow on LB agar plates containing 30 µg/ml chloramphenicol. This 
observation indicated a successful BP recombination reaction had occurred. Transformants were 
isolated from LB agar plates containing 50 µg/ml kanamycin and subjected to PCR for 
confirmation of the SAS1738 gene.  
Electrophoresis of the PCR reaction mixtures revealed bands corresponding to the size of 
SAS1738 gene, 639 Kb (Fig 7). Out of the ten transformants picked, nine showed bands 
corresponding to the size of the SAS1738 gene (~ 639 kb) as determined using a standard 1 kb 
DNA marker. 
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LR recombination  
The expression clones generated after the LR recombination reaction (Fig 8) had the 
SAS1738 encoding gene inserted into the pET-DEST42 vector in place of the ccdB and Cm
R 
genes. The transformants failed to grow on LB agar plates containing 30 µg/ml chloramphenicol. 
This observation indicated a successful LR recombination reaction had occurred. Transformants 
were isolated from LB agar plates containing 100 µg/ml ampicillin and subjected to PCR for 
confirmation of the SAS1738 gene.  
Electrophoresis of the PCR reaction mixtures revealed bands corresponding to the size of 
SAS1738 gene, 639 Kb (Fig 9). Out of the ten transformants picked, nine showed bands 
corresponding to the SAS1738 gene (≈ 639 kb) as determined using a standard 1 kb DNA 
marker. 
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Western Blot 
Following protein expression the induced and uninduced samples were subjected to 
Western blot technique as described earlier. Strong purple bands developed in less than a minute 
in lanes 2 and 3 (Fig 11). Protein bands were seen only in the induced sample but not in the 
uninduced. 
Lane 1shows the separation of the standard protein marker displaying three bands 
corresponding to 14 kd, 20 kd and 24 kd respectively (Fig 11).  The size corresponding to the 
SAS1738 was 24 kd (Fig 11) which can be seen in lanes 2 and 4. Lane 2 represents protein 
sample collected after four hours of induction while lane 3 shows sample collected after two 
hours of induction.  Lane 4 was loaded with standard protein marker and lane 5 was used for 
protein collected from uninduced sample after 4 hours. No band was seen in lane 5.  
However, two strong bands were seen, in lanes 2 and 3, one corresponding to 24 kd and 
the other to 20 kd, suggesting a possible posttranslational processing inside E. coli. Loss of the 
42 amino acid long signal peptide from SAS1738 reduces its molecular size from 24 kd to 
approximately 20 kd, which was evident from the gel (Fig 11). Since western blot involved 
lysing the cells and extracting proteins from the inclusion bodies the samples are likely to 
contain both the processed and the unprocessed proteins within the E. coli and also from the 
medium in which it has been growing. The anti-his antibody binds to the 6xhis tag that is 
towards the c-terminal end of SAS1738 and hence bands representing both the processed and the 
unprocessed can be seen on the western blot. 
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Bioassay for antibacterial activity 
Zones of lyses were observed on the Micrococcus luteus lawn (Fig. 12) when 10 µl of the 
filtered, purified and dialysed sample containing SAS1738 protein was spotted. No zones were 
observed in regions where filtered samples of the E. coli BL21 lysate and elution buffer were 
spotted.    
A zone of lysis also was observed on a lawn of Proteus vulgaris (Fig. 13) when purified 
SAS1738 was spotted. However, the lysis observed with Proteus vulgaris was not as strong as 
with M. luteus.  No zone was observed in the area where purified sample from the control 
uninduced culture was spotted. 
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Toxicity and behavior assay of C. elegans as a model host during treatment with SAS1738.   
NGM Plates were observed after incubation at 20
0
C for three days. In presence of 1 mM 
IPTG and 0.2% arabinose the first generation showed a substantial decrease in the number of 
worms on NGM plate with E. coli BL21 cells carrying the SAS1738 gene.  
The number of worms on NGM with E. coli OP50 was higher and almost equal both in 
presence and absence of 0.2% IPTG and 0.2% arabinose, indicating that IPTG or arabinose had 
no effect on the growth and development of the worms. The total number of worms on E. coli 
OP50 was 5 times higher than that estimated on NGM with E. coli BL21 cells growing in 
presence of 1 mM IPTG and 0.2% arabinose, suggesting that SAS1738 inhibited the replicative 
life cycle of C. elegans causing a decline in their number after the first generation over a period 
of 4 days. The results obtained were constant with all the five trials performed. 
 On the NGM plate where E. coli BL21 was not induced by IPTG and arabinose, the 
number of C. elegans was almost identical to the number observed on E. coli OP50 plates (Fig 
14). Five-fold fewer C. elegans were observed on plates containing E. coli BL21 induced by 
IPTG and arabinose suggesting expression of SAS1738 inhibited growth of the worms.  
In addition to the reduced population size, C. elegans growing in presence of SAS1738 
also displayed bordering (Fig 14 & 15), a phenomenon where the worms mostly concentrate on 
the edges of the bacterial lawn. No bordering phenomenon was observed in absence of SAS1738 
(Fig 14 & 15). The number of C. elegans on E. coli BL21 growing in absence of IPTG and 
arabinose is higher and shows no bordering (Top left).  Bordering is seen, and the numbers are 
reduced when SAS1738 expression in E. coli BL21 is induced by 1 mM IPTG and 0.2 % 
arabinose (Top right). The number of worms is high and no bordering appears on NMG with E. 
coli OP50. 
58 
This behavioral pattern may be a result of pathogen susceptibility which makes the 
worms prefer low oxygen concentrations found at the edges of the bacterial lawn (Reddy, 
Andersen et al. 2009). By moving to the border the worms avoid increased contact with the 
bacteria in the center of the lawn. The center of the lawn has a high concentration of bacteria 
presumably making SAS1738, which may be sensed as a potential toxin by the worms. 
Conversely SAS1738 might have induced a change in the behavior and driven the worms 
towards the edges as was evident from the results. This difference in aerotaxis behavior 
(movement in different directions that have varying oxygen concentrations) between C. elegans 
growing in presence and absence of SAS1738 combined with a 5-fold reduction in population 
size in presence of SAS1738 strongly suggests that SAS1738 might be a toxin that could induce 
behavioral changes in C. elegans and affects their replicative cycle, causing a decline in their 
numbers. 
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Inhibitory effect of SAS1738 on C. elegans growth.  
Results from the five trials of experiments are shown to demonstrate the consistent 5-fold 
reduction in the number of worms when grown on E. coli BL21 expressing SAS1738 compared 
to growth on E. coli OP50 and the uninduced E. coli BL21(Fig 16). The number of worms on 
uninduced E. coli BL21 and E. coli OP50 were approximately 800 in number after 4 days while 
the number of worms on induced E. coli BL21 was about 200 in all the five trials.  
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Confirmation of successful ligation of the gateway reading frame cassette into the 5’ MCS 
of pGFP vector by PCR and gel electrophoresis  
The expected molecular size of the new insert was approximately 1.7 kb because PCR 
primers were designed such that the forward primer included bases specific to the reading frame 
and the reverse primer spanned bases upstream from the stop codon of GFP encoding gene. The 
five transformants that were picked from a LB agar plate containing 100 µg/ml ampicillin 
showed the appropriate 1.7 kb fragment after PCR. Lane 1 represents standard 1 kb DNA marker 
showing bands corresponding to different sizes as shown in figure 15. Lanes 2-6 represent 
samples after PCR from the five transformants and each of them displayed a band corresponding 
to approximately 1.7 kb size (Fig 17). 
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Toxicity and behavioral assay of C. elegans when grown on E. coli expressing the GFP-
fused protein SAS1738.  
The number of C. elegans was higher in the presence of E. coli OP50 compared to the 
numbers on NGM containing E. coli expressing SAS1738 fused to a GFP protein (Fig 18 and Fig 
19). The number of C. elegans feeding on GFP-fused SAS1738 expressing E. coli BL21 was 
lower and their behavior was similar to those displayed when the worms were grown on E. coli 
BL21 expressing 6 x his-fused SAS1738.  This study indicated that the GFP-fused SAS1738 
retained its inhibitory effects on the growth and replicative cycle of C. elegans. 
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GFP fusion tracking of SAS1738 inside C. elegans. 
GFP-fusion tracking of SAS1738 was done in order to see which anatomic centers inside 
the worms had the highest concentration of SAS1738. In addition, this was also a test to show 
that addition of a GFP tag did not reduce the inhibitory effect on the worms. Since there was a 
similar decline in the number of worms after feeding them with GFP-fused SAS1738, it 
indicated that SAS1738 was inhibitory to the growth of worms even when fused to GFP. On the 
contrary this test was also an indication that the 6Xhis tag in itself did not confer any inhibitory 
effect on the worms since.  
 The first generation of worms were observed under a fluorescence microscope after three 
days of incubation at 21
0
 C. Fluorescence inside the worms were areas where GFP-fused 
SAS1738 were concentrated which was evident in most areas but the strongest was in the 
pharyngeal zone and in the reproductive system (Fig 20).  Intestinal lumen showed a reasonable 
amount of fluorescence as well. 
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Toxicity assay of C. elegans using purified SAS1738 
Five trials of the toxicity assay were performed and the results were plotted with time on 
the y-axis and the number of trials on the x-axis. Death of worms was based on complete lack of 
movement and cessation of pharyngeal pumping action. The death times recorded for each trial 
were 5 min, 10 min, 20 min, 7 min and 6 min when treated with purified SAS1738 (Fig. 21). The 
average death time was 8 min. No deaths occurred when worms were treated with a purified 
uninduced control sample. Each trial was performed for a total of 60 min. Each assay was carried 
out for a total of 60 min and hence the plot with respect to untreated worms flattens though the 
worms in the sample remained alive even at 60
th
 min (Fig 21). 
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Cloning and expression of SAS1738
Gateway Cloning 
BP Reaction
BP Clonase II
 
Figure 6. BP recombination reaction.   
In BP recombination reaction, attB sites on the amplified sequence containing the gene of 
interest recombine with attP sites on the pDONR 221 vector producing a recombination product 
(entry clone) bearing att L sites. 
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Transform into E.coli and 
Select for the clones on 
LB plate containing 
kanamycin
Perform colony PCR
Lane 1: 1kb marker
Lanes 2-9: cloned gene fragment corresponding to approx 0.6kb
0.5kb
1.0kb
 
Figure 7. Confirmation of entry clones on 1% agarose gel . 
The entry clone after being transformed into One Shot OmniMAX 2-T1 chemically 
competent E. coli (Invitrogen) cells were selected on kanamycin plates (40 µg/ml). PCR was 
performed and the corresponding band sizes were obtained representing the gene of interest. 
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Cloning and expression of SAS1738
Gateway Cloning
LR Reaction
LR ClonaseII
 
Figure 8. LR recombination reaction.  
The entry clone with att L sites was recombined with pET-DEST 42 vector carrying att R 
sites for LR recombination. The LR clonase II enzyme catalyses the recombination, producing an 
expression clone with the gene of interest in place of cloramphenicol resistance gene, and fused 
to V5 epitope and a 6 His tag sequence. The LR recombination reaction produces expression 
clones that bear att B sites. 
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Transform into E.coli and 
Select for the clones on 
LB plate containing ampicillin
Perform colony PCR
Lane 1: 1kb marker
Lanes 2-10: cloned gene fragment corresponding to approx 0.6kb
0.5kb
1.0kb
 
Figure 9. Confirmation of SAS1738 containing expression clones on 1% agarose gel.  
The presence of the SAS1738 gene in expression clones transformed into E. coli BL21 
A1 shot E. coli was confirmed by PCR and the expected 0.6 kb on gel electrophoresis is shown. 
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Transform into E.coli BL21 
and Select for the clones on 
LB plate containing ampicillin
Expression of SAS1738 in E.coli BL21 cells
Induce with 0.2% arabinose and 
1mM IPTG for four hours
Perform Western Blot
 
Figure 10. Transformation and expression of expression clones into E. coli BL21.   
After confirmation the E. coli BL21 cells were grown in LB containing 0.2% arabinose 
and 1 mM IPTG and induced. Expression of SAS1738 was confirmed by Western Blot. 
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Western Blot result showing a doublet at positions 
20Kd and 24Kd marker bands
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Doublet:
24Kd: Unprocessed 
peptide present within the 
E.coli cell
20Kd: Processed Protein 
possibly exported out the 
E.coli cell
 
Figure 11. Western Blot.  
Anti-his monoclonal antibody was used to determine the expression of SAS1738.Strong 
bands are seen with the sample collected at the 4th hour of induction and a slightly strong band is 
seen with the 1st hour induced sample. No band is observed in the uninduced 4th hour sample. 
Two bands are seen one corresponding to 25 kd and the other to 20 kd suggesting a possible 
post-translational processing of the protein in E. coli. Loss of the 42 amino acid signal peptide 
sequence after processing will reduce the protein size by 4.5 kd. 
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Microbiological Assay
Zones of lyses were observed on plates with Micrococcus luteus. 
 
Figure 12. Antibacterial assay results.  
Zones were observed on Micrococcus luteus lawn withpurified, dialysed and filtered 
SAS1738. No zone is seen in the two controls, one with purified, dialysed, and filtered sample of 
uninduced solution, and the other using filtered elution buffer. 
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Figure 13. Antibacterial assay.  
A Zone of lysis was observed on the lawn of Proteus vulgaris (right side of the petridish) when 
purified SAS1738 was spotted. No zone was lysis was observed on the area where purified 
sample from an uninduced culture was spotted. 
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Normal growth pattern Display of bordering 
Normal growth pattern
4 Days later…
 
Figure 14. Toxicity assay using C. elegans.  
The number of C. elegans on E. coli BL21 growing in absence of IPTG and arabinose is 
higher and shows no bordering (Top left).  Bordering is seen, and the numbers are reduced when 
73 
SAS1738 expression in E. coli BL21 is induced by 1 mM IPTG and 0.2 % arabinose (Top right). 
The number of worms is high and no bordering appears on NMG with E. coli OP50. 
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Figure 15. NGM plates displaying bordering phenomenon. 
NGM plates showing the behavioral pattern of C. elegans in presence and absence of 1 
mM IPTG and 0.2 % arabinose . Bordering is displayed on NGM in presence of SAS1738 (top 
right) and no bordering is seen in absence of SAS1738 (top left). 
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Figure 16. Inhibitory effect of SAS1738 on C. elegans growth.  
The green bar represents the number of worms consuming E. coliBL21 expressing 
SAS1738. Red bar represents the number of worms when grown on E. coli BL21 not producing 
SAS1738. Blue bar represents the number of worms growing on E. coli OP50.  
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Figure 17. 1% agarose gel confirming the insertion of reading frame cassette into pGFP 
vector.  
Confirmation of successful ligation of the gateway reading frame cassette into the 5’ 
MCS of pGFP vector by PCR and gel electrophoresis. Bands corresponding to 1.7 kb are the 
expected size and confirm the insertion of the att R containing reading frame cassette in the 5’ 
MCS of the pGFP vector. 
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Figure 18. Growth of C. elegans on E. coli OP50.  
 
Figure 19. Growth of C. elegans on E. coli BL21 expressing the GFP-fused SAS1738. 
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Figure 20. Fluorescence microscopic results of worms fed with GFP-fused SAS1738. 
Fluorescence is seen inside the worms after they were fed GFP-fused SAS1738 
expressing E. coli BL21. Fluorescence is seen throughout the body, but is strong in pharyngeal 
and reproductive areas. 
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Figure 21. Toxicity assay of C. elegans using purified, dialysed and filtered sample 
containing SAS1738.  
Toxicity assay results plotted with the number of trials of the assay on the x-axis against 
time in minutes on the y-axis. The blue diamond represents time points at which C. elegans died 
when treated with purified SAS1738 from an induced sample. The red squares represent time 
points at which C. elegans died when treated with purified uninduced control sample. 
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Discussion 
The antibacterial activity of SAS1738 against Micrococcus luteus and Proteus vulgaris in 
addition to its growth inhibition of C. elegans stresses the importance of the roles that 
hypothetical proteins of CA strains may play during an infection process in humans. The death of 
adult C. elegans in response to SAS1738 further enhances the above hypothesis. The results 
obtained from the study clearly show that SAS1738 can function in multiple ways and can 
inhibit the growth of both prokaryotic and eukaryotic cells. There are about 73 uncharacterized 
hypothetical proteins in CA strains and their potential as virulence factors can be assessed by 
testing them against C. elegans. Use of E. coli BL21 cells to express a single gene encoding a 
hypothetical protein such as SAS1738 is a method that has not been employed before. This novel 
method of feeding a toxin resistant strain of E. coli BL21cells, expressing a particular gene in 
order to determine the effects of its protein product is feasible and easy to perform. Also, the 
purified protein can be used in a killing assay of C. elegans and its effects inside a eukaryotic 
system can be assessed. 
Community associated MRSA infections have been a major public health concern since 
their emergence. The increased invasiveness of these strains has made them one of the fastest 
growing emerging infectious agents. Though they are not as resistant to a wide range of 
antibiotics as are the HA-strains, they are more invasive than the HA strains. Furthermore, CA-
MRSA has overcome regional barriers and is present in many places, including gymnasiums, 
daycares, schools, athletic training centers.  The acquisitions of novel genes, some of which 
encode major virulence factors like the PVL, have contributed to the high mortality rate from 
infections caused by the CA strains. But how they overcome the competing commensal flora of 
the human skin before they can become systemic is still not clear. However, from the results 
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obtained from our study it is evident that CA strains have an advantage over HA strains in that 
they inhibit the growth of normal flora by producing bacteriocins or antibacterial peptides.  The 
high-specificity of these antibacterial peptides prevents any cross-immunity from occurring, 
thereby making the strains that are producing them dominate over others that occupy the same 
niche (Daly, Upton et al. 2010).   
The presence of numerous as yet uncharacterized proteins encoded by hypothetical genes 
found in locations that lie in close proximity to known toxins or virulence genes suggest that the 
CA strains have invasive mechanisms that deserve further study. This may shed more light on 
their mode of pathogenesis and help in locating targets for drug designs. The killing of 
Micrococcus luteus, a normal gram positive bacteria found on the skin, nose, and in the nares, 
and a close relative of Staphylococcus aureus, strengthens the hypothesis that environmental 
competition with closely related species by producing secreted proteins is one of the features that 
makes the CA strains unique from their HA counterparts. However, mere competition with the 
normal commensal flora does not make a strain more invasive to its human host. What factors 
make some individuals more vulnerable to CA infections than others is constantly debated. The 
C. elegans toxicity assay results suggest that SAS1738 may play a dual role of inhibiting other 
commensal bacteria on the human skin as well as induce a change inside the eukaryotic system 
as evidenced by the 5-fold population reduction observed among worms treated with SAS1738. 
This dual function of SAS1738 of acting as an antibacterial peptide and as a virulence factor 
shows the complexity in the pathogenesis cycle of these bacteria. 
The less complex type IV and V SCC elements confer more flexibility to the CA strains 
thus enhancing their ability to adjust to newer environments faster than HA strains. Presence of a 
myriad of secreted protein-encoding genes is an added advantage.  However, how most of these 
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secreted proteins act on the host cell and what induces their expression are some of the questions 
that are currently addressed in most research studies. 
The mechanism by which SAS1738 causes lysis and ultimately cell death of Micrococcus 
luteus is not known, but the reduction in C. elegans population size and presence of SAS1738 
mostly in the pharyngeal and the reproductive system seems to indicate the involvement of 
lipids. Given the fact that M. luteus and Staphylococcus aureus are differentiated by an antibiotic 
susceptibility test using bacitracin which kills M. luteus but not S. aureus, it is possible that a 
similar lipid involved in the bacitracin susceptibility is involved here as well. Also most lipids 
involved in cholesterol biosynthesis are concentrated in the pharynx and reproductive regions of 
C. elegans, and fluorescence from GFP-fused SAS1738 mostly in these regions is another 
indication of the involvement of lipids. Cholesterol in oocytes is essential for the developing 
embryos, and the reduced worm population in response to SAS1738 further strengthens the 
possibility of the involvement of lipids in cholesterol synthesis in this decline in worm 
population. 
The npr-1 gene in nematodes is associated with the differences in the pathogen 
susceptibility observed among different strains of C. elegans (Reddy, Andersen et al. 2009). It 
has been shown in a previous study that the N2 strain of worms was more resistant than most 
other strains like CB4856 when exposed to a pathogen because they had an increased npr-1 gene 
activity (Reddy, Andersen et al. 2009). However, in our study N2 strains that were shown to 
have a higher npr-1 activity in fighting infections showed susceptibility to SAS1738 as 
evidenced by a significant reduction in their total number after the first generation. The other 
strains that were shown to be less effective than N2 in their pathogen fighting abilities were not 
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tested with SAS1738 in our study. It would be interesting to see how those strains might react to 
SAS1738.  
Bordering, which was shown to occur only in the CB4856 strains but not in N2 strains in 
previous study that used Pseudomonas aeruginosa strain PA14 (Reddy, Andersen et al. 2009), 
was postulated to be a behavioral pattern induced by the pathogenic environment created by the 
bacterial lawn. In our experiments, the N2 strains showed bordering and a substantial reduction 
in number in response to SAS1738. What change SAS1738 induces inside the N2 strains and 
changes its oxygen requirements as seen by a change in its aerotaxis behavior, and pushes it to 
the border is not clear.   
Alternatively, a change in the behavior as a result of stress induced by SAS1738 may lead 
to a reduction in the egg-laying and hence low population rate. Another possibility is that by 
spending more time on the edges, the worms are not acquiring enough nutrients for the proper 
development of embryos and results in a decrease in their hatchlings. Either way the effect of 
SAS1738 is detrimental to the worms. 
GFP-fused SAS1738 fed worm plates exhibited similar reduction in the worm population 
and displayed similar bordering pattern as seen with the 6xhis-fused SAS1738 fed worms. This 
study was carried out to locate SAS1738 inside the worms and also to test if the GFP tag reduced 
the effect of SAS1738. However, similar results obtained with GFP-fusion study inadvertently 
showed that the 6xhis tag in itself did not confer any inhibitory effect when fused with SAS1738.  
Toxicity testing using purified SAS1738 exhibited earlier killing of the adult worms when the 
worms were introduced into a 20 µl filtered and exposed to the sample containing SAS1738 at a 
concentration of approximately 50 µg/ml. The assay lasted 60 min and the worms treated with an 
uninduced control sample remained alive. Though the time points at which death of the worms 
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occurred when treated with SAS1738 varied with each trial, with the average time of death being 
8 min from the initial time of contact, treatment with SAS1738 resulted in death nonetheless. 
The rapid pharyngeal pumping action of the worms in liquid medium can possibly increase the 
uptake of SAS1738, which is being constantly ingested, unlike on a bacterial lawn where there 
are relatively non-toxic regions that the worms can occupy. In two of the trials, numerous eggs 
were seen in the sample after the worm was confirmed dead. In this study, the effect of SAS1738 
was determined only on the adult worms, not the eggs or the larvae. But from the plate assay 
described earlier based on a drastic decline in the number of worms after the first generation it is 
clear that SAS1738 affects the normal development of the eggs.      
Future study using a shuttle vector carrying the SAS1738 gene insert to transform a 
competent strain of Staphylococcus aureus for expression should be considered. This in 
combination with another experiment using site-directed mutagenesis for gene knock-out study 
would be interesting to further determine the effects of SAS1738 when expressed inside a 
Staphylococcus aureus system. Furthermore, this study would provide substantial data to 
delineate the activity of SAS1738. However, future study involving testing of SAS1738 on 
human cell lines will be another exciting area to explore to assess the role of SAS1738 during an 
actual MRSA infection in humans. 
SAS1738 is one of the many hypothetical proteins that are produced by CA-MRSA, most 
of which are as yet uncharacterized. This study stresses the importance of studying hypothetical 
proteins in CA-MRSA in order to better understand the versatile nature of this fast growing 
pathogen that is constantly evolving. 
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